[
    {
        "Generic Name": "Acyclovir",
        "Drug Class": "Antiviral",
        "Indications": "Herpes simplex virus (HSV) infections",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Varicella zoster virus (VZV) infections",
        "Contraindications": "Nausea ",
        "Interaction warnings & Precautions": "Probenecid may decrease acyclovir clearance increasing its levels Maintain adequate hydration to prevent nephrotoxicity especially in elderly or dehydrated patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "Lexicomp, Micromedex",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Adalimumab",
        "Drug Class": "TNF Blocker",
        "Indications": "Autoimmune disorders (RA",
        "Dosage Form": "Solution",
        "Strength": "40 mg/0.8 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Crohn's",
        "Contraindications": "psoriasis",
        "Interaction warnings & Precautions": "Live vaccines should not be given concurrently due to increased risk of infection Serious infections including tuberculosis and invasive fungal infections may occur.",
        "Storage Conditions": "Refrigerate Do Not Freeze Protect from light",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information, Briggs",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Adapalene",
        "Drug Class": "Retinoid",
        "Indications": "Acne vulgaris",
        "Dosage Form": "Gel",
        "Strength": "0.10%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin dryness",
        "Contraindications": "erythema",
        "Interaction warnings & Precautions": "No major systemic drug interactions due to minimal absorption Use of abrasive soaps or cosmetics may cause significant irritation Avoid excessive sun exposure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information, Avoid topical use on large areas",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Albendazole",
        "Drug Class": "Anthelmintic",
        "Indications": "Parasitic worm infections",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Abdominal pain",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Cimetidine praziquantel and dexamethasone can increase albandinazole sulfoxide levels Bone marrow suppression is rare but possible monitor blood counts.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Albuterol-Ipratropium",
        "Drug Class": "SABA + Anticholinergic",
        "Indications": "COPD",
        "Dosage Form": "Solution for Nebulization",
        "Strength": "3 mL/3 mL (0.5/2.5)",
        "Route of Administration": "Inhalation",
        "Side Effects": "bronchospasm",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "Beta-blockers may antagonize the effects of albuterol Use cautiously with other anticholinergic drugs to avoid additive effects Paradoxical bronchospasm may occur use a different medication if it happens.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Lexicomp, Micromedex",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Alendronate",
        "Drug Class": "Bisphosphonate",
        "Indications": "Osteoporosis",
        "Dosage Form": "Tablet",
        "Strength": "70 mg",
        "Route of Administration": "Oral",
        "Side Effects": "osteoporosis prevention",
        "Contraindications": "Esophageal irritation",
        "Interaction warnings & Precautions": "Calcium supplements antacids and other oral medications can interfere with absorption administer at least 30 minutes before any other oral product Risk of esophageal irritation and osteonecrosis of the jaw.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Allopurinol",
        "Drug Class": "Xanthine Oxidase Inhibitor",
        "Indications": "Gout",
        "Dosage Form": "Tablet",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hyperuricemia",
        "Contraindications": "Rash",
        "Interaction warnings & Precautions": "Increases concentrations of azathioprine and mercaptopurine may increase risk of rash with ampicillin and amoxicillin Severe skin reactions like Stevens-Johnson syndrome can occur discontinue at first sign of rash.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "Lexicomp, Micromedex",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Alprazolam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Anxiety disorders",
        "Dosage Form": "Tablet",
        "Strength": "0.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "panic disorder",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors like ketoconazole can significantly increase levels Risk of profound sedation respiratory depression and coma if used with opioids or alcohol Abrupt discontinuation can cause seizures.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amantadine",
        "Drug Class": "Antiviral / Antiparkinsonian",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "influenza A",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Anticholinergic drugs may have additive side effects Use cautiously in patients with seizure history or psychiatric disorders livedo reticularis and ankle edema are common.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amikacin",
        "Drug Class": "Aminoglycoside Antibiotic",
        "Indications": "Serious bacterial infections",
        "Dosage Form": "Solution",
        "Strength": "500 mg/2 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nephrotoxicity",
        "Contraindications": "ototoxicity",
        "Interaction warnings & Precautions": "Other nephrotoxic or ototoxic drugs like vancomycin or furosemide increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Aminoglycoside risk of ototoxicity)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amitriptyline",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "neuropathic pain",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs like benztropine Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amlodipine",
        "Drug Class": "Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "Peripheral edema",
        "Interaction warnings & Precautions": "Weak CYP3A4 inhibitors may increase levels but no dosage adjustment is typically needed Monitor for hypotension and peripheral edema dose-related side effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amlodipine-Benazepril",
        "Drug Class": "CCB + ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "5/20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Peripheral edema",
        "Contraindications": "cough",
        "Interaction warnings & Precautions": "NSAIDs may reduce the antihypertensive effect Lithium levels may increase Risk of angioedema can occur at any time discontinue immediately if it occurs.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amlodipine-Valsartan",
        "Drug Class": "CCB + ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5/160 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Peripheral edema",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "NSAIDs may reduce the antihypertensive effect Lithium levels may increase Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amoxicillin",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid decreases renal tubular secretion of amoxicillin May reduce efficacy of oral contraceptives Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amoxicillin-Clavulanate",
        "Drug Class": "Penicillin Antibiotic + Beta-Lactamase Inhibitor",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "875/125 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid decreases renal tubular secretion Disulfiram-like reactions have been reported with alcohol Cholestatic jaundice may occur and is usually reversible.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Amphetamine",
        "Drug Class": "CNS Stimulant",
        "Indications": "ADHD",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "narcolepsy",
        "Contraindications": "Insomnia",
        "Interaction warnings & Precautions": "MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ampicillin",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Probenecid decreases renal tubular secretion of ampicillin Allopurinol may increase the incidence of skin rashes Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ampicillin-Sulbactam",
        "Drug Class": "Penicillin Antibiotic + Beta-Lactamase Inhibitor",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "3 g (2/1 g)",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Probenecid decreases renal tubular secretion Disulfiram-like reactions have been reported with alcohol Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Anastrozole",
        "Drug Class": "Aromatase Inhibitor",
        "Indications": "Breast cancer (hormone receptor-positive)",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "arthralgia",
        "Interaction warnings & Precautions": "Tamoxifen may reduce anastrozole levels Estrogen-containing medications should not be used Decreases bone mineral density increasing fracture risk.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Apixaban",
        "Drug Class": "Direct Oral Anticoagulant (Factor Xa Inhibitor)",
        "Indications": "Stroke prevention in atrial fibrillation",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "VTE treatment",
        "Contraindications": "Bleeding",
        "Interaction warnings & Precautions": "Strong dual inducers of CYP3A4 and P-gp (eg rifampin) decrease apixaban levels increasing stroke risk Risk of serious and fatal bleeding discontinue if active bleeding occurs.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Risk of hemorrhage)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Apremilast",
        "Drug Class": "PDE4 Inhibitor",
        "Indications": "Psoriasis",
        "Dosage Form": "Tablet",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "psoriatic arthritis",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Strong CYP450 inducers (eg rifampin) reduce apremilast exposure May cause weight loss and depression monitor patient accordingly.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Aripiprazole",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "manic/mixed episodes",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg ketoconazole) or inducers (eg carbamazepine) require dose adjustment May cause suicidal thoughts and metabolic changes including weight gain and dyslipidemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Armodafinil",
        "Drug Class": "CNS Stimulant",
        "Indications": "Narcolepsy",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "sleep apnea",
        "Contraindications": "shift work disorder",
        "Interaction warnings & Precautions": "Can reduce efficacy of cyclosporine and hormonal contraceptives Strong CYP3A4 inducers or inhibitors may affect levels Serious skin reactions including Stevens-Johnson syndrome have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Asenapine",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Sublingual",
        "Side Effects": "bipolar disorder",
        "Contraindications": "Somnolence",
        "Interaction warnings & Precautions": "Strong CYP1A2 inhibitors like fluvoxamine increase asenapine levels Sublingual administration food and drink can decrease absorption May cause cerebrovascular events in elderly patients with dementia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Aspirin",
        "Drug Class": "NSAID / Antiplatelet",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "81 mg",
        "Route of Administration": "Oral",
        "Side Effects": "fever",
        "Contraindications": "inflammation",
        "Interaction warnings & Precautions": "Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Risk of closure of ductus arteriosus)",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Atenolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "tachycardia",
        "Interaction warnings & Precautions": "Calcium channel blockers like verapamil may cause bradycardia and heart failure Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Beta-blocker risk of fetal bradycardia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Atovaquone",
        "Drug Class": "Antiprotozoal",
        "Indications": "Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment",
        "Dosage Form": "Suspension",
        "Strength": "750 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Metoclopramide and rifampin reduce plasma concentrations Should not be used for serious Pneumocystis pneumonia (PCP) in patients who cannot take it with food.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Atovaquone-Proguanil",
        "Drug Class": "Antimalarial",
        "Indications": "Malaria prevention and treatment",
        "Dosage Form": "Tablet",
        "Strength": "250/100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "abdominal pain",
        "Interaction warnings & Precautions": "Metoclopramide and rifampin reduce atovaquone concentrations Not for severe malaria or prophylaxis in patients with severe renal impairment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Azathioprine",
        "Drug Class": "Immunosuppressant",
        "Indications": "Rheumatoid arthritis",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression in transplants",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Allopurinol inhibits xanthine oxidase increasing levels of active metabolites leading to severe myelosuppression Myelosuppression is dose-related and requires frequent CBC monitoring.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Azelaic Acid",
        "Drug Class": "Topical Antiacne",
        "Indications": "Rosacea",
        "Dosage Form": "Gel",
        "Strength": "15%",
        "Route of Administration": "Topical",
        "Side Effects": "acne vulgaris",
        "Contraindications": "Skin burning",
        "Interaction warnings & Precautions": "No significant drug interactions Avoid contact with eyes and mucous membranes May cause hypopigmentation in patients with dark complexions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Azithromycin",
        "Drug Class": "Macrolide Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Nelfinavir increases azithromycin levels May potentiate the effects of warfarin and digoxin May cause QT prolongation and subsequent arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bacitracin",
        "Drug Class": "Polypeptide Antibiotic",
        "Indications": "Topical skin infections",
        "Dosage Form": "Ointment",
        "Strength": "500 unit/g",
        "Route of Administration": "Topical",
        "Side Effects": "Hypersensitivity reactions",
        "Contraindications": "Hypersensitivity",
        "Interaction warnings & Precautions": "No significant systemic drug interactions due to minimal absorption For topical use only not for eyes or deep wounds.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Lexicomp, Micromedex",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Bacitracin-Polymyxin",
        "Drug Class": "Antibiotic Combination",
        "Indications": "Topical skin infections",
        "Dosage Form": "Ointment",
        "Strength": "5000-10000 unit/g",
        "Route of Administration": "Topical",
        "Side Effects": "Hypersensitivity reactions",
        "Contraindications": "Hypersensitivity to components",
        "Interaction warnings & Precautions": "No significant systemic drug interactions due to minimal absorption For topical use only not for eyes or deep wounds.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Lexicomp, Micromedex",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Baclofen",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Muscle spasticity",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants like alcohol and opioids can increase sedation Abrupt discontinuation can cause hallucinations and seizures.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Beclomethasone",
        "Drug Class": "Inhaled Corticosteroid",
        "Indications": "Asthma",
        "Dosage Form": "Inhaler",
        "Strength": "40 mcg/actuation",
        "Route of Administration": "Inhalation",
        "Side Effects": "COPD",
        "Contraindications": "Oral candidiasis",
        "Interaction warnings & Precautions": "No significant drug interactions Rinse mouth after inhalation to prevent oral candidiasis Adrenal insufficiency may occur when transferring from systemic steroids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Benazepril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bendamustine",
        "Drug Class": "Alkylating Agent",
        "Indications": "Chronic lymphocytic leukemia (CLL)",
        "Dosage Form": "Solution",
        "Strength": "25 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Inhibitors of CYP1A2 may increase bendamustine exposure Myelosuppression is common monitor blood counts regularly Infusion reactions and skin reactions may occur.",
        "Storage Conditions": "Refrigerate Protect from light",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Benzonatate",
        "Drug Class": "Antitussive",
        "Indications": "Cough suppression",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "drowsiness",
        "Interaction warnings & Precautions": "No significant drug interactions Do not chew or swallow capsules whole as it can cause local anesthesia of the oral mucosa and choking.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Benztropine",
        "Drug Class": "Anticholinergic",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "0.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "drug-induced extrapyramidal symptoms",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Use with caution in hot weather may cause heatstroke May impair mental and physical abilities required for driving.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Betamethasone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Cream",
        "Strength": "0.10%",
        "Route of Administration": "Topical",
        "Side Effects": "Hyperglycemia",
        "Contraindications": "fluid retention",
        "Interaction warnings & Precautions": "Live vaccines should not be given concurrently Phenytoin phenobarbital and rifampin reduce corticosteroid effects Systemic effects can occur with extensive topical use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bethanechol",
        "Drug Class": "Cholinergic",
        "Indications": "Urinary retention",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Abdominal cramps",
        "Contraindications": "salivation",
        "Interaction warnings & Precautions": "Other cholinergic agents can have additive effects Bethanechol is contraindicated in conditions where increased muscular activity of the GI tract or bladder might be harmful.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bisoprolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Bradycardia",
        "Interaction warnings & Precautions": "Calcium channel blockers like verapamil may cause bradycardia and heart failure Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bisoprolol-Hydrochlorothiazide",
        "Drug Class": "Beta-Blocker + Thiazide Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5/6.25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bradycardia",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased May exacerbate glucose intolerance and hyperlipidemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (ACE Inhibitor/Thiazide risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bortezomib",
        "Drug Class": "Proteasome Inhibitor",
        "Indications": "Multiple myeloma",
        "Dosage Form": "Powder for Injection",
        "Strength": "3.5 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Peripheral neuropathy",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Peripheral neuropathy is a common and sometimes severe toxicity requiring dose adjustment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bosentan",
        "Drug Class": "Endothelin Receptor Antagonist",
        "Indications": "Pulmonary arterial hypertension (PAH)",
        "Dosage Form": "Tablet",
        "Strength": "62.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "nasopharyngitis",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers like rifampin decrease levels and inhibitors like ketoconazole increase levels Requires monthly monitoring of liver enzymes due to risk of hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Brexpiprazole",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "adjunct for depression",
        "Contraindications": "Weight gain",
        "Interaction warnings & Precautions": "Strong CYP3A4 or CYP2D6 inhibitors require dose adjustment May cause suicidal thoughts and metabolic changes including weight gain and dyslipidemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Brimonidine",
        "Drug Class": "Alpha-2 Adrenergic Agonist",
        "Indications": "Glaucoma",
        "Dosage Form": "Solution",
        "Strength": "0.10%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "ocular hypertension",
        "Contraindications": "Ocular allergy",
        "Interaction warnings & Precautions": "CNS depressants may potentiate effects MAOIs may potentiate vasoconstrictive effect May cause fatigue and drowsiness in some patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Brinzolamide",
        "Drug Class": "Carbonic Anhydrase Inhibitor",
        "Indications": "Glaucoma",
        "Dosage Form": "Suspension",
        "Strength": "1%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "ocular hypertension",
        "Contraindications": "Blurred vision",
        "Interaction warnings & Precautions": "Oral carbonic anhydrase inhibitors may have additive effects Salicylates may cause acid-base disturbances Sulfonamide hypersensitivity reactions may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bromocriptine",
        "Drug Class": "Dopamine Agonist",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hyperprolactinemia",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Other drugs that lower blood pressure may have additive effects Ergot-related drugs may cause fibrosis of cardiac valves with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Budesonide",
        "Drug Class": "Inhaled Corticosteroid",
        "Indications": "Asthma",
        "Dosage Form": "Suspension for Nebulization",
        "Strength": "3 mg/2 mL",
        "Route of Administration": "Inhalation",
        "Side Effects": "COPD",
        "Contraindications": "Oral candidiasis",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors like ketoconazole may increase systemic exposure Rinse mouth after inhalation to prevent oral candidiasis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bumetanide",
        "Drug Class": "Loop Diuretic",
        "Indications": "Edema (heart failure",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hepatic",
        "Contraindications": "renal)",
        "Interaction warnings & Precautions": "Other ototoxic drugs may increase risk of hearing loss Indomethacin may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Buprenorphine",
        "Drug Class": "Opioid Partial Agonist",
        "Indications": "Pain management",
        "Dosage Form": "Tablet",
        "Strength": "8 mg",
        "Route of Administration": "Sublingual",
        "Side Effects": "opioid use disorder",
        "Contraindications": "Constipation",
        "Interaction warnings & Precautions": "Benzodiazepines and other CNS depressants increase risk of respiratory depression Can precipitate withdrawal in patients dependent on other opioids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Bupropion",
        "Drug Class": "Atypical Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet (SR)",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "smoking cessation",
        "Contraindications": "Insomnia",
        "Interaction warnings & Precautions": "MAOIs can increase risk of hypertensive episodes Lowers seizure threshold in a dose-dependent manner.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Buspirone",
        "Drug Class": "Anxiolytic",
        "Indications": "Generalized anxiety disorder",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "MAOIs may increase blood pressure Use cautiously with other CNS depressants Not effective for benzodiazepine withdrawal.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Butalbital-Acetaminophen-Caffeine",
        "Drug Class": "Barbiturate + Analgesic",
        "Indications": "Tension headache",
        "Dosage Form": "Tablet",
        "Strength": "50/325/40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol can cause additive sedation Barbiturate component induces CYP450 enzymes reducing efficacy of many drugs.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Barbiturate risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Butoconazole",
        "Drug Class": "Antifungal",
        "Indications": "Vaginal yeast infections",
        "Dosage Form": "Cream",
        "Strength": "2%",
        "Route of Administration": "Vaginal",
        "Side Effects": "Vaginal burning",
        "Contraindications": "itching",
        "Interaction warnings & Precautions": "No significant drug interactions For vaginal use only not for ophthalmic or oral use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Cabergoline",
        "Drug Class": "Dopamine Agonist",
        "Indications": "Hyperprolactinemia",
        "Dosage Form": "Tablet",
        "Strength": "0.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Other drugs that lower blood pressure may have additive effects Ergot-related drugs may cause fibrosis of cardiac valves with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Calcipotriene",
        "Drug Class": "Vitamin D Analog",
        "Indications": "Plaque psoriasis",
        "Dosage Form": "Ointment",
        "Strength": "0.01%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin irritation",
        "Contraindications": "hypercalcemia",
        "Interaction warnings & Precautions": "No significant drug interactions Topical use only excessive use can lead to hypercalcemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Calcitonin",
        "Drug Class": "Calcium Regulator",
        "Indications": "Hypercalcemia",
        "Dosage Form": "Spray",
        "Strength": "200 IU/actuation",
        "Route of Administration": "Nasal",
        "Side Effects": "osteoporosis",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "No significant drug interactions Potential for serious allergic reactions including anaphylaxis.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Calcitriol",
        "Drug Class": "Vitamin D Analog",
        "Indications": "Hypocalcemia",
        "Dosage Form": "Capsule",
        "Strength": "0.25 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypercalcemia",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Cholestyramine may impair absorption Magnesium-containing antacids may cause hypermagnesemia Can cause hypercalcemia monitor serum calcium levels.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Hypercalcemia risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Calcium Carbonate",
        "Drug Class": "Antacid / Calcium Supplement",
        "Indications": "Antacid",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "calcium supplementation",
        "Contraindications": "Constipation",
        "Interaction warnings & Precautions": "Can decrease absorption of tetracyclines and fluoroquinolones administer separately Excessive use can cause hypercalcemia and milk-alkali syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Generally considered safe in pregnancy",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Canagliflozin",
        "Drug Class": "SGLT2 Inhibitor",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Genital mycotic infections",
        "Contraindications": "UTI",
        "Interaction warnings & Precautions": "Rifampin decreases canagliflozin levels May increase risk of hypotension with diuretics Can cause genital mycotic infections and volume depletion.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Not recommended in 2nd/3rd trim)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Candesartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "8 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Hyperkalemia",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Capecitabine",
        "Drug Class": "Antimetabolite",
        "Indications": "Breast cancer",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "colorectal cancer",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Warfarin interaction can lead to serious bleeding and death Patients with DPD deficiency are at risk for severe toxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Captopril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of neutropenia and agranulocytosis particularly in renal impairment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Carbamazepine",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "trigeminal neuralgia",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Induces CYP450 enzymes reducing levels of many drugs (eg oral contraceptives warfarin) HLA-B*1502 allele increases risk of serious skin reactions in certain populations.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Neural tube defect risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Carbidopa",
        "Drug Class": "Decarboxylase Inhibitor",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Nonselective MAOIs are contraindicated When given without levodopa it has no therapeutic effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Carboplatin",
        "Drug Class": "Alkylating Agent",
        "Indications": "Ovarian cancer",
        "Dosage Form": "Solution",
        "Strength": "10 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "other cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Nephrotoxic drugs may enhance platinum-induced renal toxicity Myelosuppression is dose-related and is the dose-limiting toxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Carisoprodol",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Muscle pain",
        "Dosage Form": "Tablet",
        "Strength": "350 mg",
        "Route of Administration": "Oral",
        "Side Effects": "spasms",
        "Contraindications": "Drowsiness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol can cause additive sedation Metabolism produces meprobamate a controlled substance with abuse potential.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Carvedilol",
        "Drug Class": "Alpha/Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "12.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Bradycardia",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Caspofungin",
        "Drug Class": "Echinocandin Antifungal",
        "Indications": "Invasive fungal infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "70 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Fever",
        "Contraindications": "phlebitis",
        "Interaction warnings & Precautions": "Cyclosporine increases caspofungin exposure and may cause elevated liver enzymes Not for use in hepatic impairment.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefaclor",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion Nephrotoxicity may occur with concurrent use of potent diuretics.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefadroxil",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion Nephrotoxicity may occur with concurrent use of potent diuretics.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefazolin",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion Nephrotoxicity may occur with concurrent use of potent diuretics.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefdinir",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Antacids and iron supplements decrease absorption May cause red stools due to interaction with iron.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefditoren",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion Contraindicated in patients with carnitine deficiency or milk protein allergy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefepime",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Nephrotoxic drugs may increase the risk of kidney damage May cause neurotoxicity including encephalopathy and nonconvulsive status epilepticus especially in renal impairment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefixime",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefotaxime",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefoxitin",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "2 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefpodoxime",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Antacids and H2 blockers decrease absorption May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefprozil",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ceftaroline",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "600 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that prolong the QT interval may have additive effects May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ceftazidime",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "2 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ceftibuten",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cefuroxime",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Celecoxib",
        "Drug Class": "COX-2 Inhibitor",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Capsule",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "pain",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events including MI and stroke.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cephalexin",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease cephalosporin excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cetirizine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "urticaria",
        "Contraindications": "Somnolence",
        "Interaction warnings & Precautions": "No significant drug interactions at recommended doses May cause somnolence although less than first-generation antihistamines.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Chloramphenicol",
        "Drug Class": "Antibiotic",
        "Indications": "Serious infections (e.g.",
        "Dosage Form": "Ointment",
        "Strength": "0.50%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "meningitis",
        "Contraindications": "typhoid fever)",
        "Interaction warnings & Precautions": "Potentiates effects of warfarin phenytoin and sulfonylureas by inhibiting their metabolism Associated with serious and fatal blood dyscrasias like aplastic anemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Gray baby syndrome risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Chlordiazepoxide",
        "Drug Class": "Benzodiazepine",
        "Indications": "Anxiety disorders",
        "Dosage Form": "Capsule",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "alcohol withdrawal",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Chlorthalidone",
        "Drug Class": "Thiazide Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "edema",
        "Contraindications": "Hypokalemia",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Thiazide risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cholecalciferol",
        "Drug Class": "Vitamin D Supplement",
        "Indications": "Vitamin D deficiency",
        "Dosage Form": "Softgel",
        "Strength": "2000 IU",
        "Route of Administration": "Oral",
        "Side Effects": "Hypercalcemia",
        "Contraindications": "Hypercalcemia",
        "Interaction warnings & Precautions": "Cholestyramine and mineral oil may reduce absorption Excessive intake can lead to hypercalcemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Hypercalcemia risk)",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Ciclopirox",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Gel",
        "Strength": "0.77%",
        "Route of Administration": "Topical",
        "Side Effects": "nail infections",
        "Contraindications": "Skin irritation",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cidofovir",
        "Drug Class": "Antiviral",
        "Indications": "Cytomegalovirus (CMV) retinitis",
        "Dosage Form": "Solution",
        "Strength": "375 mg/5 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nephrotoxicity",
        "Contraindications": "neutropenia",
        "Interaction warnings & Precautions": "Probenecid is required during administration to reduce nephrotoxicity and other nephrotoxic drugs should be avoided Causes severe nephrotoxicity requires pre-hydration and renal function monitoring.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cilostazol",
        "Drug Class": "Phosphodiesterase Inhibitor",
        "Indications": "Intermittent claudication",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Strong CYP3A4 or CYP2C19 inhibitors (eg omeprazole) may increase levels Contraindicated in patients with heart failure of any severity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cimetidine",
        "Drug Class": "H2 Blocker",
        "Indications": "Peptic ulcer disease",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GERD",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Inhibits CYP450 enzymes increasing levels of many drugs (eg warfarin phenytoin) Mental confusion and dizziness are more common in elderly or severely ill patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Cinacalcet",
        "Drug Class": "Calcimimetic",
        "Indications": "Hyperparathyroidism",
        "Dosage Form": "Tablet",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause hypocalcemia monitor serum calcium levels closely.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ciprofloxacin",
        "Drug Class": "Fluoroquinolone Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with tendonitis and tendon rupture.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Arthropathy risk in animals)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cisplatin",
        "Drug Class": "Alkylating Agent",
        "Indications": "Various cancers",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nephrotoxicity",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Nephrotoxic drugs enhance cisplatin-induced kidney damage Ototoxicity is cumulative and may be severe and irreversible.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Citalopram",
        "Drug Class": "SSRI",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and other SSRIs may have additive effects Causes dose-dependent QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clarithromycin",
        "Drug Class": "Macrolide Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Inhibits CYP3A4 increasing levels of many drugs (eg statins carbamazepine) May cause QT prolongation and subsequent arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clindamycin",
        "Drug Class": "Lincosamide Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea (including C. difficile)",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "May enhance the effects of neuromuscular blocking agents Causes severe and sometimes fatal Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clobetasol",
        "Drug Class": "Topical Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Cream",
        "Strength": "0.05%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin atrophy",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions Systemic absorption can cause reversible HPA axis suppression with potential for glucocorticosteroid insufficiency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clomiphene",
        "Drug Class": "Selective Estrogen Receptor Modulator (SERM)",
        "Indications": "Ovulation induction",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Ovarian enlargement",
        "Contraindications": "hot flashes",
        "Interaction warnings & Precautions": "No significant drug interactions May cause visual disturbances and ovarian hyperstimulation syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clomipramine",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Obsessive-compulsive disorder (OCD)",
        "Dosage Form": "Capsule",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clonazepam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "panic disorder",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal seizures.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clonidine",
        "Drug Class": "Alpha-2 Agonist",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "0.1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "ADHD",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Abrupt discontinuation can cause rebound hypertension and nervousness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clopidogrel",
        "Drug Class": "Antiplatelet",
        "Indications": "Cardiovascular event prevention",
        "Dosage Form": "Tablet",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bleeding",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Proton pump inhibitors like omeprazole may reduce its antiplatelet effect Risk of bleeding including life-threatening and fatal bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clorazepate",
        "Drug Class": "Benzodiazepine",
        "Indications": "Anxiety disorders",
        "Dosage Form": "Tablet",
        "Strength": "7.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Clotrimazole",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Cream",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "vaginal yeast infections",
        "Contraindications": "Skin irritation",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Clozapine",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Treatment-resistant schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "sialorrhea",
        "Interaction warnings & Precautions": "Bone marrow suppressants may increase risk of agranulocytosis Can cause severe neutropenia and agranulocytosis requiring mandatory WBC monitoring.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Codeine",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "cough",
        "Contraindications": "Constipation",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur especially in CYP2D6 ultra-rapid metabolizers.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Colchicine",
        "Drug Class": "Antigout",
        "Indications": "Gout flares",
        "Dosage Form": "Tablet",
        "Strength": "0.6 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Strong CYP3A4 or P-gp inhibitors (eg clarithromycin) dramatically increase levels and risk of fatal toxicity Can cause myelosuppression with chronic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Colesevelam",
        "Drug Class": "Bile Acid Sequestrant",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "625 mg",
        "Route of Administration": "Oral",
        "Side Effects": "type 2 diabetes",
        "Contraindications": "Constipation",
        "Interaction warnings & Precautions": "Can decrease the absorption of many other drugs (eg warfarin phenytoin) administer other drugs 4 hours before colesevelam Can cause constipation and may increase triglycerides.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Conjugated Estrogens",
        "Drug Class": "Estrogen",
        "Indications": "Hormone replacement",
        "Dosage Form": "Tablet",
        "Strength": "0.625 mg",
        "Route of Administration": "Oral",
        "Side Effects": "osteoporosis prevention",
        "Contraindications": "Breast tenderness",
        "Interaction warnings & Precautions": "Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cromolyn",
        "Drug Class": "Mast Cell Stabilizer",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Spray",
        "Strength": "5.2 mg/actuation",
        "Route of Administration": "Nasal",
        "Side Effects": "asthma",
        "Contraindications": "Throat irritation",
        "Interaction warnings & Precautions": "No significant drug interactions Not for acute treatment of an asthma attack.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cyclobenzaprine",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Muscle spasms",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Drowsiness",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "MAOIs are contraindicated due to risk of serotonin syndrome and hyperpyrexia May impair mental and physical abilities required for driving.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cyclophosphamide",
        "Drug Class": "Alkylating Agent",
        "Indications": "Various cancers",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Allopurinol may increase the risk of leukopenia Can cause hemorrhagic cystitis and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cyclosporine",
        "Drug Class": "Immunosuppressant",
        "Indications": "Organ transplant rejection",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "autoimmune disorders",
        "Contraindications": "Nephrotoxicity",
        "Interaction warnings & Precautions": "Many drugs can increase levels (eg ketoconazole) or decrease levels (eg rifampin) Nephrotoxicity and hypertension are common dose-related toxicities.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Cyproheptadine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic reactions",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "appetite stimulation",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects May cause drowsiness and impair mental and physical abilities.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dabigatran",
        "Drug Class": "Direct Thrombin Inhibitor",
        "Indications": "Stroke prevention in atrial fibrillation",
        "Dosage Form": "Capsule",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "VTE treatment",
        "Contraindications": "Bleeding",
        "Interaction warnings & Precautions": "P-gp inducers (eg rifampin) decrease levels and P-gp inhibitors (eg dronedarone) increase levels Risk of serious and sometimes fatal bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Risk of hemorrhage)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dabrafenib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Melanoma (BRAF V600E mutation)",
        "Dosage Form": "Capsule",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperkeratosis",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers or inhibitors may alter levels May promote the growth of certain skin cancers monitor for new malignancies.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dacarbazine",
        "Drug Class": "Alkylating Agent",
        "Indications": "Hodgkin's lymphoma",
        "Dosage Form": "Powder for Injection",
        "Strength": "200 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "melanoma",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Phenytoin may reduce efficacy Can cause severe nausea and vomiting and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dactinomycin",
        "Drug Class": "Antitumor Antibiotic",
        "Indications": "Various cancers",
        "Dosage Form": "Powder for Injection",
        "Strength": "0.5 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Radiation therapy can recall skin reactions Can cause severe myelosuppression and extravasation injury.",
        "Storage Conditions": "Refrigerate Protect from light",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dalbavancin",
        "Drug Class": "Glycopeptide Antibiotic",
        "Indications": "Bacterial skin infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "500 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "No significant drug interactions Prolonged terminal half-life allows for once-weekly dosing.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dantrolene",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Malignant hyperthermia",
        "Dosage Form": "Capsule",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "spasticity",
        "Contraindications": "Muscle weakness",
        "Interaction warnings & Precautions": "CNS depressants and estrogens may enhance hepatotoxicity Can cause hepatotoxicity and muscle weakness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dapsone",
        "Drug Class": "Antibacterial",
        "Indications": "Leprosy",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "dermatitis herpetiformis",
        "Contraindications": "Hemolytic anemia",
        "Interaction warnings & Precautions": "Rifampin decreases levels trimethoprim increases levels Can cause hemolytic anemia and methemoglobinemia especially in G6PD deficiency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Daptomycin",
        "Drug Class": "Lipopeptide Antibiotic",
        "Indications": "Complicated skin infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "500 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myopathy",
        "Contraindications": "CPK elevation",
        "Interaction warnings & Precautions": "HMG-CoA reductase inhibitors may increase risk of myopathy May cause myopathy and rhabdomyolysis monitor CPK levels.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Darunavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers (eg rifampin) are contraindicated as they significantly decrease levels May cause severe skin reactions and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dasatinib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Chronic myeloid leukemia (CML)",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "fluid retention",
        "Interaction warnings & Precautions": "Antacids and H2 blockers decrease absorption May cause severe myelosuppression and fluid retention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Daunorubicin",
        "Drug Class": "Anthracycline Antibiotic",
        "Indications": "Leukemias",
        "Dosage Form": "Powder for Injection",
        "Strength": "20 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "cardiotoxicity",
        "Interaction warnings & Precautions": "Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Deferasirox",
        "Drug Class": "Iron Chelator",
        "Indications": "Iron overload",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Avoid concurrent administration with aluminum-containing antacids Can cause renal impairment and hepatic failure monitor function regularly.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Deferoxamine",
        "Drug Class": "Iron Chelator",
        "Indications": "Iron overload",
        "Dosage Form": "Powder for Injection",
        "Strength": "500 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypotension",
        "Contraindications": "ocular/auditory toxicity",
        "Interaction warnings & Precautions": "Prochlorperazine may cause loss of consciousness Can cause ocular and auditory toxicity with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Delavirdine",
        "Drug Class": "NNRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Antacids and H2 blockers decrease absorption CYP3A4 inhibitors or inducers will affect levels Rash is a common side effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Denosumab",
        "Drug Class": "RANK Ligand Inhibitor",
        "Indications": "Osteoporosis",
        "Dosage Form": "Solution",
        "Strength": "60 mg/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "bone metastases",
        "Contraindications": "Hypocalcemia",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause severe hypocalcemia must correct pre-existing hypocalcemia prior to use.",
        "Storage Conditions": "Refrigerate Do Not Freeze Protect from light",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Desipramine",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Desloratadine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "urticaria",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "No significant drug interactions at recommended doses Rarely may cause somnolence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Desmopressin",
        "Drug Class": "Vasopressin Analog",
        "Indications": "Diabetes insipidus",
        "Dosage Form": "Tablet",
        "Strength": "0.1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "enuresis",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Other drugs that may increase the risk of water intoxication and hyponatremia Can cause hyponatremia and water intoxication monitor sodium levels.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Desogestrel-Ethinyl Estradiol",
        "Drug Class": "Progestin + Estrogen",
        "Indications": "Contraception",
        "Dosage Form": "Tablet",
        "Strength": "0.15/0.03 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg rifampin) can decrease efficacy and increase breakthrough bleeding Increases risk of thromboembolic disorders and stroke.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Desonide",
        "Drug Class": "Topical Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Ointment",
        "Strength": "0.05%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin atrophy",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions Systemic absorption can occur with extensive use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Desoximetasone",
        "Drug Class": "Topical Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Cream",
        "Strength": "0.25%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin atrophy",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions Systemic absorption can occur with extensive use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dexamethasone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression",
        "Contraindications": "Hyperglycemia",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dexlansoprazole",
        "Drug Class": "Proton Pump Inhibitor",
        "Indications": "GERD",
        "Dosage Form": "Capsule (DR)",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "erosive esophagitis",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dexmethylphenidate",
        "Drug Class": "CNS Stimulant",
        "Indications": "ADHD",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Insomnia",
        "Contraindications": "decreased appetite",
        "Interaction warnings & Precautions": "MAOIs are contraindicated due to risk of hypertensive crisis May exacerbate pre-existing psychosis and cause peripheral vasculopathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dextroamphetamine",
        "Drug Class": "CNS Stimulant",
        "Indications": "ADHD",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "narcolepsy",
        "Contraindications": "Insomnia",
        "Interaction warnings & Precautions": "MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Diazepam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Anxiety disorders",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "alcohol withdrawal",
        "Contraindications": "muscle spasms",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Diclofenac",
        "Drug Class": "NSAID",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "inflammation",
        "Contraindications": "osteoarthritis",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dicloxacillin",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dicyclomine",
        "Drug Class": "Anticholinergic",
        "Indications": "Irritable bowel syndrome",
        "Dosage Form": "Capsule",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Contraindicated in patients with glaucoma or severe ulcerative colitis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Didanosine",
        "Drug Class": "NRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Peripheral neuropathy",
        "Contraindications": "pancreatitis",
        "Interaction warnings & Precautions": "Drugs that cause pancreatitis or peripheral neuropathy increase risk Can cause severe pancreatitis and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Digoxin",
        "Drug Class": "Cardiac Glycoside",
        "Indications": "Heart failure",
        "Dosage Form": "Tablet",
        "Strength": "0.125 mg",
        "Route of Administration": "Oral",
        "Side Effects": "atrial fibrillation",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Many drugs can increase levels (eg amiodarone verapamil) causing toxicity Can cause life-threatening arrhythmias due to its narrow therapeutic index.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dihydroergotamine",
        "Drug Class": "Ergot Alkaloid",
        "Indications": "Migraine attacks",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg clarithromycin) are contraindicated due to risk of ergotism Contraindicated in coronary artery disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Diltiazem",
        "Drug Class": "Non-Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule (ER)",
        "Strength": "120 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "Bradycardia",
        "Interaction warnings & Precautions": "CYP3A4 inhibitors can increase levels and inducers can decrease levels Can cause bradycardia and heart failure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dimethyl Fumarate",
        "Drug Class": "Fumaric Acid Ester",
        "Indications": "Multiple sclerosis",
        "Dosage Form": "Capsule (DR)",
        "Strength": "240 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Flushing",
        "Contraindications": "abdominal pain",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause flushing and GI events (nausea diarrhea abdominal pain) usually at treatment initiation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dinoprostone",
        "Drug Class": "Prostaglandin",
        "Indications": "Cervical ripening",
        "Dosage Form": "Insert",
        "Strength": "10 mg",
        "Route of Administration": "Vaginal",
        "Side Effects": "labor induction",
        "Contraindications": "Uterine hyperstimulation",
        "Interaction warnings & Precautions": "Other oxytocic agents may have additive effects Can cause uterine hyperstimulation which may progress to uterine rupture.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Diphenhydramine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic reactions",
        "Dosage Form": "Capsule",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "insomnia",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects May cause marked drowsiness and impair mental and physical abilities.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Diphenoxylate-Atropine",
        "Drug Class": "Antidiarrheal",
        "Indications": "Diarrhea",
        "Dosage Form": "Tablet",
        "Strength": "2.5/0.025 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause paralytic ileus and toxic megacolon in patients with infectious diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dipyridamole",
        "Drug Class": "Antiplatelet",
        "Indications": "Post-cardiac valve replacement",
        "Dosage Form": "Tablet",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Theophylline may antagonize the antiplatelet effect Can cause angina pectoris and hypotension in patients with coronary artery disease.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Disopyramide",
        "Drug Class": "Antiarrhythmic (Class Ia)",
        "Indications": "Ventricular arrhythmias",
        "Dosage Form": "Capsule (CR)",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Anticholinergic effects (dry mouth",
        "Contraindications": "urinary retention)",
        "Interaction warnings & Precautions": "Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause heart failure and severe anticholinergic side effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Disulfiram",
        "Drug Class": "Aldehyde Dehydrogenase Inhibitor",
        "Indications": "Alcohol use disorder",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Drowsiness",
        "Contraindications": "metallic taste",
        "Interaction warnings & Precautions": "Metronidazole and alcohol-containing products can cause a disulfiram-like reaction Can cause hepatotoxicity and psychiatric disturbances.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Divalproex",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet (ER)",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "migraine prevention",
        "Interaction warnings & Precautions": "CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Neural tube defect risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Docetaxel",
        "Drug Class": "Antimicrotubule Agent",
        "Indications": "Breast cancer",
        "Dosage Form": "Solution",
        "Strength": "20 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "other cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause severe fluid retention and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Docusate",
        "Drug Class": "Stool Softener",
        "Indications": "Constipation",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Abdominal cramping",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Mineral oil may increase systemic absorption of the oil Can cause mild abdominal cramping.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Dofetilide",
        "Drug Class": "Antiarrhythmic (Class III)",
        "Indications": "Atrial fibrillation/flutter",
        "Dosage Form": "Capsule",
        "Strength": "125 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Many drugs are contraindicated including verapamil and cimetidine as they inhibit secretion and increase levels Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dolasetron",
        "Drug Class": "5-HT3 Antagonist",
        "Indications": "Chemotherapy-induced nausea/vomiting",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Drugs that prolong the QT interval may have additive effects Can cause QT prolongation and subsequent arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Donepezil",
        "Drug Class": "Cholinesterase Inhibitor",
        "Indications": "Alzheimer's disease",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Other cholinergic agents can have additive effects Can cause nausea vomiting diarrhea and bradycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dopamine",
        "Drug Class": "Catecholamine",
        "Indications": "Shock",
        "Dosage Form": "Solution",
        "Strength": "40 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "hypotension",
        "Contraindications": "Tachycardia",
        "Interaction warnings & Precautions": "MAOIs can cause severe hypertension Extravasation can cause tissue necrosis and sloughing.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Doripenem",
        "Drug Class": "Carbapenem Antibiotic",
        "Indications": "Complicated infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "500 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dornase Alfa",
        "Drug Class": "Mucolytic",
        "Indications": "Cystic fibrosis",
        "Dosage Form": "Solution for Nebulization",
        "Strength": "2.5 mg/2.5 mL",
        "Route of Administration": "Inhalation",
        "Side Effects": "Voice alteration",
        "Contraindications": "pharyngitis",
        "Interaction warnings & Precautions": "No significant drug interactions For inhalation use only must be used with a recommended nebulizer.",
        "Storage Conditions": "Refrigerate Do Not Shake",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Doxazosin",
        "Drug Class": "Alpha-1 Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "BPH",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Doxepin",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Capsule",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "insomnia",
        "Contraindications": "Pruritus",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Doxercalciferol",
        "Drug Class": "Vitamin D Analog",
        "Indications": "Hypoparathyroidism",
        "Dosage Form": "Capsule",
        "Strength": "0.5 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypercalcemia",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Cholestyramine may impair absorption Can cause hypercalcemia and hyperphosphatemia monitor serum levels.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Hypercalcemia risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Doxorubicin",
        "Drug Class": "Anthracycline Antibiotic",
        "Indications": "Various cancers",
        "Dosage Form": "Solution",
        "Strength": "2 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "cardiotoxicity",
        "Interaction warnings & Precautions": "Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.",
        "Storage Conditions": "Refrigerate Protect from light",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Doxycycline",
        "Drug Class": "Tetracycline Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Photosensitivity",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Antacids and calcium supplements decrease absorption Can cause photosensitivity and esophageal irritation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Tooth discoloration risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dronabinol",
        "Drug Class": "Cannabinoid",
        "Indications": "Chemotherapy-induced nausea/vomiting",
        "Dosage Form": "Capsule",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "appetite stimulation",
        "Contraindications": "Drowsiness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol can cause additive sedation Can cause profound psychological effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Droperidol",
        "Drug Class": "Antipsychotic",
        "Indications": "Nausea/vomiting",
        "Dosage Form": "Solution",
        "Strength": "2.5 mg/mL",
        "Route of Administration": "Intramuscular",
        "Side Effects": "sedation",
        "Contraindications": "QT prolongation",
        "Interaction warnings & Precautions": "Other QT-prolonging agents increase risk of torsades de pointes Can cause QT prolongation and severe hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Drospirenone-Ethinyl Estradiol",
        "Drug Class": "Progestin + Estrogen",
        "Indications": "Contraception",
        "Dosage Form": "Tablet",
        "Strength": "3/0.02 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may increase risk of hyperkalemia Increases risk of thromboembolic disorders and hyperkalemia in high-risk patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Duloxetine",
        "Drug Class": "SNRI",
        "Indications": "Depression",
        "Dosage Form": "Capsule",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "anxiety",
        "Contraindications": "diabetic neuropathy",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome Can cause hepatotoxicity and increase suicidal thoughts and behaviors.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Dutasteride",
        "Drug Class": "5-alpha Reductase Inhibitor",
        "Indications": "BPH",
        "Dosage Form": "Capsule",
        "Strength": "0.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Decreased libido",
        "Contraindications": "erectile dysfunction",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Pregnant women should not handle crushed capsules due to risk of fetal abnormality.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Echinacea",
        "Drug Class": "Herbal Supplement",
        "Indications": "Immune support",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "cold symptoms",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "May interact with drugs metabolized by CYP450 enzymes Not recommended for use in autoimmune diseases or with immunosuppressants.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Insufficient data",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Econazole",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Cream",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin irritation",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Eculizumab",
        "Drug Class": "Monoclonal Antibody",
        "Indications": "Paroxysmal nocturnal hemoglobinuria (PNH)",
        "Dosage Form": "Solution",
        "Strength": "300 mg/30 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "aHUS",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Vaccination with live vaccines is not recommended Increases risk of serious meningococcal infections vaccination required at least 2 weeks prior.",
        "Storage Conditions": "Refrigerate Do Not Freeze Protect from light",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Efavirenz",
        "Drug Class": "NNRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Induces CYP3A4 and inhibits CYP2C9/CYP2C19 affecting many drugs Can cause severe psychiatric symptoms and rash.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Eletriptan",
        "Drug Class": "5-HT1 Agonist",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Chest pain",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg ketoconazole) are contraindicated due to increased risk of coronary vasospasm Contraindicated in ischemic heart disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Emedastine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Solution",
        "Strength": "0.05%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Headache",
        "Contraindications": "burning sensation",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only may cause mild transient stinging or burning.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Empagliflozin",
        "Drug Class": "SGLT2 Inhibitor",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Genital mycotic infections",
        "Interaction warnings & Precautions": "Diuretics may enhance the potential for volume depletion Can cause genital mycotic infections and volume depletion.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Not recommended in 2nd/3rd trim)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Enalapril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Enalapril-Hydrochlorothiazide",
        "Drug Class": "ACE Inhibitor + Thiazide Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "10/25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Cough",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased May exacerbate glucose intolerance and hyperlipidemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor/Thiazide risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Enfuvirtide",
        "Drug Class": "Fusion Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Powder for Injection",
        "Strength": "90 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Injection site reactions",
        "Contraindications": "insomnia",
        "Interaction warnings & Precautions": "No significant drug interactions Almost all patients experience injection site reactions.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Enoxaparin",
        "Drug Class": "Low Molecular Weight Heparin",
        "Indications": "VTE prophylaxis and treatment",
        "Dosage Form": "Solution",
        "Strength": "40 mg/0.4 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "bleeding",
        "Contraindications": "anemia",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Can cause spinal or epidural hematoma leading to paralysis with neuraxial anesthesia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Entacapone",
        "Drug Class": "COMT Inhibitor",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "urine discoloration",
        "Interaction warnings & Precautions": "Nonselective MAOIs are contraindicated Can cause diarrhea and urine discoloration.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Entecavir",
        "Drug Class": "Nucleoside Reverse Transcriptase Inhibitor",
        "Indications": "Hepatitis B",
        "Dosage Form": "Tablet",
        "Strength": "0.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Drugs that reduce renal function may increase levels Severe acute exacerbations of hepatitis B have been reported upon discontinuation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Enzalutamide",
        "Drug Class": "Androgen Receptor Inhibitor",
        "Indications": "Prostate cancer",
        "Dosage Form": "Capsule",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Strong CYP2C8 inhibitors may increase levels and inducers may decrease levels Can cause seizures and posterior reversible encephalopathy syndrome (PRES).",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Epinastine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Solution",
        "Strength": "0.05%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Headache",
        "Contraindications": "burning sensation",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only may cause mild transient burning or stinging.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Epinephrine",
        "Drug Class": "Alpha/Beta Agonist",
        "Indications": "Anaphylaxis",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intramuscular",
        "Side Effects": "cardiac arrest",
        "Contraindications": "Tachycardia",
        "Interaction warnings & Precautions": "Beta-blockers may antagonize cardiac effects and cause severe hypertension Can cause angina and arrhythmias in patients with heart disease.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Epirubicin",
        "Drug Class": "Anthracycline Antibiotic",
        "Indications": "Breast cancer",
        "Dosage Form": "Solution",
        "Strength": "2 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "other cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Eplerenone",
        "Drug Class": "Aldosterone Antagonist",
        "Indications": "Heart failure",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hypertension",
        "Contraindications": "Hyperkalemia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg ketoconazole) are contraindicated Can cause hyperkalemia particularly in patients with renal impairment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Epoetin Alfa",
        "Drug Class": "Erythropoiesis-Stimulating Agent",
        "Indications": "Anemia of chronic kidney disease",
        "Dosage Form": "Solution",
        "Strength": "4000 units/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypertension",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions Increases risk of serious cardiovascular events thromboembolic events and mortality when dosed to a target Hb over 11 g/dL.",
        "Storage Conditions": "Refrigerate Do Not Shake",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Eprosartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "upper respiratory infection",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Eptifibatide",
        "Drug Class": "Glycoprotein IIb/IIIa Inhibitor",
        "Indications": "Acute coronary syndrome",
        "Dosage Form": "Solution",
        "Strength": "2 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Bleeding",
        "Contraindications": "hypotension",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Can cause serious bleeding and thrombocytopenia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ergocalciferol",
        "Drug Class": "Vitamin D",
        "Indications": "Vitamin D deficiency",
        "Dosage Form": "000 unit",
        "Strength": "50",
        "Route of Administration": "Capsule",
        "Side Effects": "Hypercalcemia",
        "Contraindications": "Hypercalcemia",
        "Interaction warnings & Precautions": "Cholestyramine and mineral oil may reduce absorption Excessive intake can lead to hypercalcemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Hypercalcemia risk)",
        "Availability": "Oral"
    },
    {
        "Generic Name": "Ergoloid Mesylates",
        "Drug Class": "Ergot Alkaloid",
        "Indications": "Dementia (cognitive decline)",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions Not for use in the treatment of psychosis or acute mental disorders.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ergotamine",
        "Drug Class": "Ergot Alkaloid",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Sublingual",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg clarithromycin) are contraindicated due to risk of ergotism Contraindicated in coronary artery disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ertapenem",
        "Drug Class": "Carbapenem Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intramuscular",
        "Side Effects": "Diarrhea",
        "Contraindications": "infusion site reactions",
        "Interaction warnings & Precautions": "Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Erythromycin",
        "Drug Class": "Macrolide Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Inhibits CYP3A4 increasing levels of many drugs (eg statins carbamazepine) May cause QT prolongation and subsequent arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Escitalopram",
        "Drug Class": "SSRI",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "anxiety disorders",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and other SSRIs may have additive effects May increase risk of bleeding especially with NSAIDs or warfarin.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Esmolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Tachycardia",
        "Dosage Form": "Solution",
        "Strength": "10 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "supraventricular tachycardia",
        "Contraindications": "Hypotension",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Can cause profound hypotension and bradycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Esomeprazole",
        "Drug Class": "Proton Pump Inhibitor",
        "Indications": "GERD",
        "Dosage Form": "Capsule (DR)",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "erosive esophagitis",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Estazolam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Insomnia",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Estradiol",
        "Drug Class": "Estrogen",
        "Indications": "Hormone replacement",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "osteoporosis prevention",
        "Contraindications": "Breast tenderness",
        "Interaction warnings & Precautions": "Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Eszopiclone",
        "Drug Class": "Non-Benzodiazepine Hypnotic",
        "Indications": "Insomnia",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Unpleasant taste",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "CNS depressants including alcohol increase sedation risk May cause complex sleep behaviors like sleep-driving.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ethambutol",
        "Drug Class": "Antimycobacterial",
        "Indications": "Tuberculosis",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Optic neuritis",
        "Contraindications": "hyperuricemia",
        "Interaction warnings & Precautions": "Aluminum hydroxide may decrease absorption Can cause optic neuritis leading to decreased visual acuity and color blindness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ethosuximide",
        "Drug Class": "Anticonvulsant",
        "Indications": "Absence seizures",
        "Dosage Form": "Capsule",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Drowsiness",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause blood dyscrasias including aplastic anemia and SLE.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Etodolac",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "pain",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Etonogestrel",
        "Drug Class": "Progestin",
        "Indications": "Contraception (implant)",
        "Dosage Form": "Implant",
        "Strength": "68 mg",
        "Route of Administration": "Subdermal",
        "Side Effects": "Headache",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "Hepatic enzyme inducers may decrease efficacy and increase breakthrough bleeding Must be removed if a patient becomes pregnant.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Implant)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Etoposide",
        "Drug Class": "Topoisomerase Inhibitor",
        "Indications": "Various cancers",
        "Dosage Form": "Capsule",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and secondary leukemias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Everolimus",
        "Drug Class": "mTOR Inhibitor",
        "Indications": "Organ transplant rejection",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "certain cancers",
        "Contraindications": "Stomatitis",
        "Interaction warnings & Precautions": "Strong CYP3A4 or P-gp inhibitors may increase levels and inducers may decrease levels Can cause non-infectious pneumonitis and immunosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Exemestane",
        "Drug Class": "Aromatase Inhibitor",
        "Indications": "Breast cancer",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Estrogen-containing medications should not be used Decreases bone mineral density increasing fracture risk.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Exenatide",
        "Drug Class": "GLP-1 Receptor Agonist",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Solution",
        "Strength": "10 mcg/0.4 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Nausea",
        "Contraindications": "hypoglycemia",
        "Interaction warnings & Precautions": "Drugs that are rapidly absorbed may be delayed (eg antibiotics) Can cause nausea and increased risk of thyroid C-cell tumors in rodents.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ezetimibe",
        "Drug Class": "Cholesterol Absorption Inhibitor",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "arthralgia",
        "Interaction warnings & Precautions": "Cholestyramine decreases ezetimibe levels Fibrates may increase the risk of cholelithiasis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Famciclovir",
        "Drug Class": "Antiviral",
        "Indications": "Herpes zoster",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "herpes simplex",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Probenecid may decrease renal excretion of penciclovir Dosage adjustment is required in renal impairment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Famotidine",
        "Drug Class": "H2 Blocker",
        "Indications": "Peptic ulcer disease",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GERD",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "No significant drug interactions May cause confusion more commonly in elderly or severely ill patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Felbamate",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Anorexia",
        "Contraindications": "insomnia",
        "Interaction warnings & Precautions": "Increases levels of phenytoin and valproic acid and decreases levels of carbamazepine Can cause aplastic anemia and hepatic failure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Felodipine",
        "Drug Class": "Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet (ER)",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Peripheral edema",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg ketoconazole) can significantly increase levels Can cause peripheral edema and gingival hyperplasia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fenofibrate",
        "Drug Class": "Fibrate",
        "Indications": "Hypertriglyceridemia",
        "Dosage Form": "Tablet",
        "Strength": "145 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Can potentiate the effects of warfarin increasing INR Can cause cholelithiasis and myopathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fentanyl",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain management",
        "Dosage Form": "Patch",
        "Strength": "25 mcg/hr",
        "Route of Administration": "Transdermal",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ferrous Sulfate",
        "Drug Class": "Iron Supplement",
        "Indications": "Iron deficiency anemia",
        "Dosage Form": "Tablet",
        "Strength": "325 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Antacids and tetracyclines decrease absorption Can cause GI irritation and constipation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Fesoterodine",
        "Drug Class": "Anticholinergic",
        "Indications": "Overactive bladder",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause urinary retention and blurred vision.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fexofenadine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Tablet",
        "Strength": "180 mg",
        "Route of Administration": "Oral",
        "Side Effects": "urticaria",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Aluminum and magnesium-containing antacids decrease absorption Rarely may cause headache or drowsiness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Finasteride",
        "Drug Class": "5-alpha Reductase Inhibitor",
        "Indications": "BPH",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "male pattern hair loss",
        "Contraindications": "Decreased libido",
        "Interaction warnings & Precautions": "No significant drug interactions Pregnant women should not handle crushed tablets due to risk of fetal abnormality.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Flecainide",
        "Drug Class": "Antiarrhythmic (Class Ic)",
        "Indications": "Ventricular arrhythmias",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "atrial fibrillation",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Other drugs that prolong the QT interval increase risk of proarrhythmia Can cause new or worsened arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluconazole",
        "Drug Class": "Azole Antifungal",
        "Indications": "Fungal infections",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Inhibits CYP2C9 and CYP3A4 increasing levels of many drugs (eg warfarin phenytoin) Can cause QT prolongation and subsequent arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fludarabine",
        "Drug Class": "Antimetabolite",
        "Indications": "Chronic lymphocytic leukemia (CLL)",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "fever",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and neurotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fludrocortisone",
        "Drug Class": "Corticosteroid",
        "Indications": "Adrenal insufficiency",
        "Dosage Form": "Tablet",
        "Strength": "0.1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperglycemia",
        "Contraindications": "fluid retention",
        "Interaction warnings & Precautions": "Other drugs that lower potassium may have additive effects Can cause hypertension and hypokalemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Flumazenil",
        "Drug Class": "Benzodiazepine Antagonist",
        "Indications": "Benzodiazepine overdose",
        "Dosage Form": "Solution",
        "Strength": "0.1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Dizziness",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Can precipitate acute withdrawal in patients dependent on benzodiazepines Seizures may occur especially in patients on long-term benzodiazepines.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluocinolone",
        "Drug Class": "Topical Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Solution",
        "Strength": "0.01%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin atrophy",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions Systemic absorption can occur with extensive use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluocinonide",
        "Drug Class": "Topical Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Cream",
        "Strength": "0.05%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin atrophy",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions Systemic absorption can occur with extensive use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluorometholone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory eye conditions",
        "Dosage Form": "Suspension",
        "Strength": "0.10%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Increased intraocular pressure",
        "Contraindications": "blurred vision",
        "Interaction warnings & Precautions": "No significant drug interactions May increase intraocular pressure and cause cataract formation with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluorouracil",
        "Drug Class": "Antimetabolite",
        "Indications": "Various cancers",
        "Dosage Form": "Powder for Injection",
        "Strength": "500 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "mucositis",
        "Interaction warnings & Precautions": "Leucovorin enhances the toxicity and efficacy Can cause severe myelosuppression and mucositis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluoxetine",
        "Drug Class": "SSRI",
        "Indications": "Depression",
        "Dosage Form": "Capsule",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "OCD",
        "Contraindications": "panic disorder",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and other SSRIs may have additive effects May increase risk of bleeding especially with NSAIDs or warfarin.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluphenazine",
        "Drug Class": "Typical Antipsychotic",
        "Indications": "Psychotic disorders",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Extrapyramidal symptoms",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Flurazepam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Insomnia",
        "Dosage Form": "Capsule",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Flurbiprofen",
        "Drug Class": "NSAID",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "inflammation",
        "Contraindications": "osteoarthritis",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Flutamide",
        "Drug Class": "Antiandrogen",
        "Indications": "Prostate cancer",
        "Dosage Form": "Capsule",
        "Strength": "125 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "loss of libido",
        "Interaction warnings & Precautions": "Warfarin metabolism is inhibited increasing INR Can cause hepatotoxicity and gynecomastia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluticasone",
        "Drug Class": "Inhaled Corticosteroid",
        "Indications": "Asthma",
        "Dosage Form": "Inhaler",
        "Strength": "110 mcg/actuation",
        "Route of Administration": "Inhalation",
        "Side Effects": "COPD",
        "Contraindications": "Oral candidiasis",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors like ketoconazole may increase systemic exposure Rinse mouth after inhalation to prevent oral candidiasis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluvastatin",
        "Drug Class": "Statin",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Capsule (ER)",
        "Strength": "80 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "myalgia",
        "Interaction warnings & Precautions": "Can increase the effects of warfarin and other drugs metabolized by CYP2C9 Can cause myopathy and rhabdomyolysis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fluvoxamine",
        "Drug Class": "SSRI",
        "Indications": "Obsessive-compulsive disorder (OCD)",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "Strong inhibitor of CYP1A2 and CYP2C19 affecting many drugs (eg theophylline clozapine) May increase risk of bleeding especially with NSAIDs or warfarin.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Folic Acid",
        "Drug Class": "Vitamin",
        "Indications": "Folate deficiency",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "megaloblastic anemia",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Folate antagonists like methotrexate are inhibited Can mask the hematological signs of vitamin B12 deficiency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Formoterol",
        "Drug Class": "LABA",
        "Indications": "Asthma",
        "Dosage Form": "Capsule for Inhalation",
        "Strength": "12 mcg",
        "Route of Administration": "Inhalation",
        "Side Effects": "COPD",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fosamprenavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "700 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Induces CYP3A4 and inhibits CYP2C9 affecting many drugs Can cause severe skin reactions and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Foscarnet",
        "Drug Class": "Antiviral",
        "Indications": "Cytomegalovirus (CMV) retinitis",
        "Dosage Form": "Solution",
        "Strength": "24 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nephrotoxicity",
        "Contraindications": "electrolyte imbalances",
        "Interaction warnings & Precautions": "Nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and electrolyte imbalances.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fosfomycin",
        "Drug Class": "Antibiotic",
        "Indications": "Uncomplicated UTIs",
        "Dosage Form": "Packet",
        "Strength": "3 g",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Metoclopramide may decrease serum levels Generally well-tolerated with diarrhea being the most common side effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fosphenytoin",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Solution",
        "Strength": "50 mg PE/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "status epilepticus",
        "Contraindications": "Nystagmus",
        "Interaction warnings & Precautions": "Many drugs can increase or decrease phenytoin levels Can cause life-threatening dermatologic reactions like Stevens-Johnson syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Frovatriptan",
        "Drug Class": "5-HT1 Agonist",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Other 5-HT1 agonists can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Fulvestrant",
        "Drug Class": "Estrogen Receptor Antagonist",
        "Indications": "Breast cancer",
        "Dosage Form": "Solution",
        "Strength": "250 mg/5 mL",
        "Route of Administration": "Intramuscular",
        "Side Effects": "Nausea",
        "Contraindications": "hot flashes",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause injection site reactions and nausea.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Furosemide",
        "Drug Class": "Loop Diuretic",
        "Indications": "Edema (heart failure",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hepatic",
        "Contraindications": "renal)",
        "Interaction warnings & Precautions": "Other ototoxic drugs may increase risk of hearing loss NSAIDs may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gabapentin",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "neuropathic pain",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Antacids decrease absorption May cause somnolence dizziness and respiratory depression especially with opioids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gadobutrol",
        "Drug Class": "Contrast Agent",
        "Indications": "MRI contrast",
        "Dosage Form": "Solution",
        "Strength": "1 mmol/10 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Headache",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "No significant drug interactions Contraindicated in patients with known gadolinium sensitivity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ganciclovir",
        "Drug Class": "Antiviral",
        "Indications": "Cytomegalovirus (CMV) infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "fever",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and mutagenesis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gefitinib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Non-small cell lung cancer (NSCLC)",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can cause interstitial lung disease and diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gemcitabine",
        "Drug Class": "Antimetabolite",
        "Indications": "Pancreatic cancer",
        "Dosage Form": "Powder for Injection",
        "Strength": "200 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "other cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and hemolytic uremic syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gemfibrozil",
        "Drug Class": "Fibrate",
        "Indications": "Hypertriglyceridemia",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dyspepsia",
        "Contraindications": "abdominal pain",
        "Interaction warnings & Precautions": "Potentiates the effects of warfarin and increases risk of myopathy with statins Can cause cholelithiasis and myopathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gentamicin",
        "Drug Class": "Aminoglycoside Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Ointment",
        "Strength": "0.10%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Nephrotoxicity",
        "Contraindications": "ototoxicity",
        "Interaction warnings & Precautions": "Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Aminoglycoside risk of ototoxicity)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Glatiramer",
        "Drug Class": "Immunomodulator",
        "Indications": "Multiple sclerosis",
        "Dosage Form": "Solution",
        "Strength": "20 mg/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Injection site reactions",
        "Contraindications": "flushing",
        "Interaction warnings & Precautions": "No significant drug reactions Can cause immediate post-injection reaction (flushing chest pain palpitations).",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Glibenclamide",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Sulfonylurea risk of hypoglycemia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Gliclazide",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "80 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Not FDA approved; generally considered C",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Glimepiride",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Sulfonylurea risk of hypoglycemia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Glipizide",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Sulfonylurea risk of hypoglycemia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Glucagon",
        "Drug Class": "Hyperglycemic Agent",
        "Indications": "Severe hypoglycemia",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "No significant drug interactions Administer glucose upon recovery to prevent rebound hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Glyburide",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Sulfonylurea risk of hypoglycemia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Golimumab",
        "Drug Class": "TNF Blocker",
        "Indications": "Autoimmune disorders (RA",
        "Dosage Form": "Solution",
        "Strength": "50 mg/0.5 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "psoriatic arthritis)",
        "Contraindications": "Upper respiratory infection",
        "Interaction warnings & Precautions": "Live vaccines should not be given concurrently due to increased risk of infection Serious infections including tuberculosis and invasive fungal infections may occur.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Goserelin",
        "Drug Class": "GnRH Agonist",
        "Indications": "Prostate cancer",
        "Dosage Form": "Implant",
        "Strength": "3.6 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "breast cancer",
        "Contraindications": "endometriosis",
        "Interaction warnings & Precautions": "No significant drug interactions Causes an initial increase in testosterone levels which may worsen symptoms in prostate cancer patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Granisetron",
        "Drug Class": "5-HT3 Antagonist",
        "Indications": "Chemotherapy-induced nausea/vomiting",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "No significant drug interactions Generally well-tolerated with headache being the most common side effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Griseofulvin",
        "Drug Class": "Antifungal",
        "Indications": "Fungal infections of skin",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hair",
        "Contraindications": "nails",
        "Interaction warnings & Precautions": "Warfarin metabolism is decreased increasing INR Can cause photosensitivity and lupus-like syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Guanfacine",
        "Drug Class": "Alpha-2 Agonist",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "ADHD",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Abrupt discontinuation can cause rebound hypertension and nervousness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Halobetasol",
        "Drug Class": "Topical Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Ointment",
        "Strength": "0.05%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin atrophy",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions Systemic absorption can occur with extensive use leading to adrenal suppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Haloperidol",
        "Drug Class": "Typical Antipsychotic",
        "Indications": "Psychotic disorders",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Tourette's syndrome",
        "Contraindications": "Extrapyramidal symptoms",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Heparin",
        "Drug Class": "Anticoagulant",
        "Indications": "VTE prophylaxis and treatment",
        "Dosage Form": "Solution",
        "Strength": "5000 units/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "bleeding",
        "Contraindications": "heparin-induced thrombocytopenia",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Can cause heparin-induced thrombocytopenia (HIT) and bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Homatropine",
        "Drug Class": "Anticholinergic",
        "Indications": "Ocular cycloplegia",
        "Dosage Form": "Solution",
        "Strength": "5%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "mydriasis",
        "Contraindications": "Blurred vision",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Contraindicated in patients with angle-closure glaucoma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydralazine",
        "Drug Class": "Vasodilator",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "tachycardia",
        "Interaction warnings & Precautions": "MAOIs may cause excessive hypotension Can cause drug-induced lupus erythematosus and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydrochlorothiazide",
        "Drug Class": "Thiazide Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "edema",
        "Contraindications": "Hypokalemia",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Thiazide risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydrocodone",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Cough",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydrocortisone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Cream",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "adrenal insufficiency",
        "Contraindications": "Hyperglycemia",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Hydromorphone",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydroxychloroquine",
        "Drug Class": "Antimalarial / DMARD",
        "Indications": "Malaria",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "lupus",
        "Contraindications": "rheumatoid arthritis",
        "Interaction warnings & Precautions": "Can cause retinal toxicity requiring regular ophthalmologic exams Can cause retinal toxicity and QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydroxyurea",
        "Drug Class": "Antimetabolite",
        "Indications": "Sickle cell anemia",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "certain cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and macrocytic anemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hydroxyzine",
        "Drug Class": "Antihistamine",
        "Indications": "Anxiety",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "pruritus",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects May cause marked drowsiness and QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Hyoscyamine",
        "Drug Class": "Anticholinergic",
        "Indications": "GI spasms",
        "Dosage Form": "Tablet",
        "Strength": "0.125 mg",
        "Route of Administration": "Oral",
        "Side Effects": "irritable bowel syndrome",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Contraindicated in patients with glaucoma or severe ulcerative colitis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ibandronate",
        "Drug Class": "Bisphosphonate",
        "Indications": "Osteoporosis",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Esophageal irritation",
        "Contraindications": "musculoskeletal pain",
        "Interaction warnings & Precautions": "Calcium supplements and other oral medications can interfere with absorption Risk of esophageal irritation and osteonecrosis of the jaw.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ibrutinib",
        "Drug Class": "BTK Inhibitor",
        "Indications": "Chronic lymphocytic leukemia (CLL)",
        "Dosage Form": "Capsule",
        "Strength": "140 mg",
        "Route of Administration": "Oral",
        "Side Effects": "mantle cell lymphoma",
        "Contraindications": "Bleeding",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause bleeding infections and atrial fibrillation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ibuprofen",
        "Drug Class": "NSAID",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "fever",
        "Contraindications": "inflammation",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Ibutilide",
        "Drug Class": "Antiarrhythmic (Class III)",
        "Indications": "Atrial fibrillation/flutter",
        "Dosage Form": "Solution",
        "Strength": "0.1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Headache",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Idarubicin",
        "Drug Class": "Anthracycline Antibiotic",
        "Indications": "Leukemias",
        "Dosage Form": "Solution",
        "Strength": "5 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "cardiotoxicity",
        "Interaction warnings & Precautions": "Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ifosfamide",
        "Drug Class": "Alkylating Agent",
        "Indications": "Various cancers",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "hemorrhagic cystitis",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause hemorrhagic cystitis (requires Mesna) and neurotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Iloperidone",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "Strong CYP2D6 or CYP3A4 inhibitors require dose adjustment Can cause orthostatic hypotension and QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Imatinib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Chronic myeloid leukemia (CML)",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI stromal tumor",
        "Contraindications": "Fluid retention",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can cause fluid retention and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Imipenem-Cilastatin",
        "Drug Class": "Carbapenem Antibiotic",
        "Indications": "Serious bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "500 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Imipramine",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "enuresis",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Indapamide",
        "Drug Class": "Thiazide-like Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypokalemia",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Thiazide-like risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Indomethacin",
        "Drug Class": "NSAID",
        "Indications": "Gout",
        "Dosage Form": "Capsule",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "pain",
        "Contraindications": "inflammation",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Infliximab",
        "Drug Class": "TNF Blocker",
        "Indications": "Autoimmune disorders (Crohn's",
        "Dosage Form": "Powder for Injection",
        "Strength": "100 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "RA)",
        "Contraindications": "Infusion reactions",
        "Interaction warnings & Precautions": "Live vaccines should not be given concurrently due to increased risk of infection Serious infections including tuberculosis and invasive fungal infections may occur.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Insulin Aspart",
        "Drug Class": "Insulin (Rapid-Acting)",
        "Indications": "Diabetes mellitus",
        "Dosage Form": "Solution",
        "Strength": "100 unit/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Insulin Detemir",
        "Drug Class": "Insulin (Long-Acting)",
        "Indications": "Diabetes mellitus",
        "Dosage Form": "Solution",
        "Strength": "100 unit/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Insulin Glulisine",
        "Drug Class": "Insulin (Rapid-Acting)",
        "Indications": "Diabetes mellitus",
        "Dosage Form": "Solution",
        "Strength": "100 unit/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Insulin Lispro",
        "Drug Class": "Insulin (Rapid-Acting)",
        "Indications": "Diabetes mellitus",
        "Dosage Form": "Solution",
        "Strength": "100 unit/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "Drugs that affect glucose metabolism (eg corticosteroids beta-blockers) Can cause severe hypoglycemia and hypokalemia.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Interferon Alfa-2b",
        "Drug Class": "Immunomodulator",
        "Indications": "Hepatitis B/C",
        "Dosage Form": "Powder for Injection",
        "Strength": "10 million unit",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "certain cancers",
        "Contraindications": "Flu-like symptoms",
        "Interaction warnings & Precautions": "Theophylline clearance may be decreased Can cause severe psychiatric effects and myelosuppression.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ipratropium",
        "Drug Class": "Anticholinergic",
        "Indications": "COPD",
        "Dosage Form": "Solution for Nebulization",
        "Strength": "0.03%",
        "Route of Administration": "Inhalation",
        "Side Effects": "asthma",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Irbesartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "diabetic nephropathy",
        "Contraindications": "Hyperkalemia",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Irinotecan",
        "Drug Class": "Topoisomerase Inhibitor",
        "Indications": "Colorectal cancer",
        "Dosage Form": "Solution",
        "Strength": "20 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "myelosuppression",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers or inhibitors may alter levels Can cause severe delayed diarrhea and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Isavuconazole",
        "Drug Class": "Azole Antifungal",
        "Indications": "Invasive fungal infections",
        "Dosage Form": "Capsule",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can cause hepatotoxicity and infusion-related reactions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Isoniazid",
        "Drug Class": "Antimycobacterial",
        "Indications": "Tuberculosis",
        "Dosage Form": "Tablet",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hepatotoxicity",
        "Contraindications": "peripheral neuropathy",
        "Interaction warnings & Precautions": "Inhibits CYP450 enzymes increasing levels of many drugs (eg phenytoin) Can cause severe hepatotoxicity and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Isosorbide Dinitrate",
        "Drug Class": "Nitrate",
        "Indications": "Angina pectoris",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "hypotension",
        "Interaction warnings & Precautions": "Phosphodiesterase inhibitors (eg sildenafil) can cause severe hypotension Can cause tolerance with continuous use and severe headaches.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Isosorbide Mononitrate",
        "Drug Class": "Nitrate",
        "Indications": "Angina pectoris",
        "Dosage Form": "Tablet",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "hypotension",
        "Interaction warnings & Precautions": "Phosphodiesterase inhibitors (eg sildenafil) can cause severe hypotension Can cause tolerance with continuous use and severe headaches.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Isotretinoin",
        "Drug Class": "Retinoid",
        "Indications": "Severe nodular acne",
        "Dosage Form": "Capsule",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry skin",
        "Contraindications": "cheilitis",
        "Interaction warnings & Precautions": "Vitamin A supplements can cause additive toxicity and tetracyclines increase risk of pseudotumor cerebri Highly teratogenic requires strict pregnancy prevention program.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (iPLEDGE program)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Itraconazole",
        "Drug Class": "Azole Antifungal",
        "Indications": "Fungal infections",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Inhibits CYP3A4 increasing levels of many drugs (eg statins) Contraindicated with drugs that prolong QT interval and can cause negative inotropy and heart failure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ivabradine",
        "Drug Class": "Hyperpolarization-Activated Cyclic NucleotideGated (HCN) Channel Blocker",
        "Indications": "Heart failure",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "Bradycardia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause bradycardia and phosphenes (visual brightness).",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ivacaftor",
        "Drug Class": "CFTR Potentiator",
        "Indications": "Cystic fibrosis",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "upper respiratory infection",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause elevated liver enzymes and non-congenital cataracts.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ivermectin",
        "Drug Class": "Anthelmintic",
        "Indications": "Parasitic infections",
        "Dosage Form": "Tablet",
        "Strength": "3 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "pruritus",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause Mazzotti reaction (inflammatory response) in patients with high parasitic load.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ketoconazole",
        "Drug Class": "Azole Antifungal",
        "Indications": "Fungal infections",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitor that can significantly increase levels of many drugs (eg statins) Contraindicated due to risk of hepatotoxicity and adrenal insufficiency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ketoprofen",
        "Drug Class": "NSAID",
        "Indications": "Pain",
        "Dosage Form": "Capsule",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "inflammation",
        "Contraindications": "osteoarthritis",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ketorolac",
        "Drug Class": "NSAID",
        "Indications": "Pain (short-term management)",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI upset",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious bleeding and renal impairment.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ketotifen",
        "Drug Class": "Antihistamine / Mast Cell Stabilizer",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Solution",
        "Strength": "0.03%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Drowsiness",
        "Contraindications": "dry eyes",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects For ophthalmic use only may cause transient stinging.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Labetalol",
        "Drug Class": "Alpha/Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bradycardia",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Can cause liver injury and bronchospasm in susceptible patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lacosamide",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions May cause dizziness and PR interval prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lamivudine",
        "Drug Class": "NRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hepatitis B",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Trimethoprim/sulfamethoxazole increases lamivudine exposure Severe acute exacerbations of hepatitis B have been reported upon discontinuation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lamotrigine",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Valproic acid increases lamotrigine levels while carbamazepine decreases them Can cause serious skin rashes including Stevens-Johnson syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lansoprazole",
        "Drug Class": "Proton Pump Inhibitor",
        "Indications": "GERD",
        "Dosage Form": "Capsule (DR)",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "erosive esophagitis",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Latanoprost",
        "Drug Class": "Prostaglandin Analog",
        "Indications": "Glaucoma",
        "Dosage Form": "Solution",
        "Strength": "0.01%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "ocular hypertension",
        "Contraindications": "Eye color change",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause increased pigmentation of the iris and eyelashes.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Leflunomide",
        "Drug Class": "DMARD",
        "Indications": "Rheumatoid arthritis",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Ooral",
        "Side Effects": "Diarrhea",
        "Contraindications": "elevated LFTs",
        "Interaction warnings & Precautions": "Activated charcoal or cholestyramine can accelerate elimination Can cause hepatotoxicity and teratogenicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Letrozole",
        "Drug Class": "Aromatase Inhibitor",
        "Indications": "Breast cancer",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "arthralgia",
        "Interaction warnings & Precautions": "Tamoxifen may reduce letrozole levels Estrogen-containing medications should not be used Decreases bone mineral density increasing fracture risk.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Leuprolide",
        "Drug Class": "GnRH Agonist",
        "Indications": "Prostate cancer",
        "Dosage Form": "Powder for Injection",
        "Strength": "3.75 mg",
        "Route of Administration": "Intramuscular",
        "Side Effects": "endometriosis",
        "Contraindications": "uterine fibroids",
        "Interaction warnings & Precautions": "No significant drug interactions Causes an initial increase in testosterone levels which may worsen symptoms in prostate cancer patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levalbuterol",
        "Drug Class": "SABA",
        "Indications": "Asthma",
        "Dosage Form": "Solution for Nebulization",
        "Strength": "0.63 mg/3 mL",
        "Route of Administration": "Inhalation",
        "Side Effects": "bronchospasm",
        "Contraindications": "Tachycardia",
        "Interaction warnings & Precautions": "Beta-blockers may antagonize the effects Can cause paradoxical bronchospasm and cardiovascular effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levetiracetam",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Somnolence",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "No significant drug interactions May cause behavioral abnormalities including psychosis and aggression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levocabastine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Suspension",
        "Strength": "0.05%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Headache",
        "Contraindications": "burning sensation",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only may cause mild transient stinging.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levocarnitine",
        "Drug Class": "Carnitine Supplement",
        "Indications": "Carnitine deficiency",
        "Dosage Form": "Solution",
        "Strength": "1 g/10 mL",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause nausea and vomiting.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levocetirizine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "urticaria",
        "Contraindications": "Somnolence",
        "Interaction warnings & Precautions": "No significant drug interactions at recommended doses Rarely may cause somnolence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Levodopa",
        "Drug Class": "Dopamine Precursor",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Nonselective MAOIs are contraindicated and pyridoxine can reverse its effects in the periphery Can cause orthostatic hypotension and hallucinations.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levofloxacin",
        "Drug Class": "Fluoroquinolone Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with tendonitis and tendon rupture.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Arthropathy risk in animals)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Levothyroxine",
        "Drug Class": "Thyroid Hormone",
        "Indications": "Hypothyroidism",
        "Dosage Form": "Tablet",
        "Strength": "50 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Palpitations",
        "Contraindications": "weight loss",
        "Interaction warnings & Precautions": "Many drugs can decrease absorption (eg calcium iron) Can cause cardiac ischemia and arrhythmias in overdose.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lidocaine",
        "Drug Class": "Local Anesthetic / Antiarrhythmic (Class Ib)",
        "Indications": "Local anesthesia",
        "Dosage Form": "Jelly",
        "Strength": "2%",
        "Route of Administration": "Topical",
        "Side Effects": "ventricular arrhythmias",
        "Contraindications": "CNS toxicity (dizziness",
        "Interaction warnings & Precautions": "Beta-blockers may increase the risk of lidocaine toxicity Can cause CNS toxicity (seizures) and cardiovascular collapse.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Linagliptin",
        "Drug Class": "DPP-4 Inhibitor",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nasopharyngitis",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions May cause hypersensitivity reactions including anaphylaxis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Linezolid",
        "Drug Class": "Oxazolidinone Antibiotic",
        "Indications": "Bacterial infections (e.g.",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "VRE)",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Can cause serotonin syndrome with serotonergic drugs like SSRIs Can cause myelosuppression and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Liothyronine",
        "Drug Class": "Thyroid Hormone",
        "Indications": "Hypothyroidism",
        "Dosage Form": "Tablet",
        "Strength": "5 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Palpitations",
        "Contraindications": "weight loss",
        "Interaction warnings & Precautions": "Many drugs can decrease absorption (eg calcium iron) Can cause cardiac ischemia and arrhythmias in overdose.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Liotrix",
        "Drug Class": "Thyroid Hormone",
        "Indications": "Hypothyroidism",
        "Dosage Form": "Tablet",
        "Strength": "15/60 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Palpitations",
        "Contraindications": "weight loss",
        "Interaction warnings & Precautions": "Many drugs can decrease absorption (eg calcium iron) Can cause cardiac ischemia and arrhythmias in overdose.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lisinopril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lithium",
        "Drug Class": "Antimanic",
        "Indications": "Bipolar disorder",
        "Dosage Form": "Capsule",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "tremor",
        "Interaction warnings & Precautions": "NSAIDs and diuretics can decrease renal clearance and increase levels Can cause lithium toxicity which requires monitoring of serum levels.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Cardiac risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lodoxamide",
        "Drug Class": "Mast Cell Stabilizer",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Solution",
        "Strength": "0.10%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Burning",
        "Contraindications": "stinging",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only may cause transient burning or stinging.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lomefloxacin",
        "Drug Class": "Fluoroquinolone Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "photosensitivity",
        "Interaction warnings & Precautions": "Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with photosensitivity and tendon rupture.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Arthropathy risk in animals)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lomustine",
        "Drug Class": "Alkylating Agent",
        "Indications": "Brain tumors",
        "Dosage Form": "Capsule",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hodgkin's lymphoma",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause delayed myelosuppression and pulmonary fibrosis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Loperamide",
        "Drug Class": "Antidiarrheal",
        "Indications": "Diarrhea",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "QT prolongation has been reported with high doses Can cause toxic megacolon in patients with infectious diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Lopinavir-Ritonavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "200/50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Induces and inhibits various CYP450 enzymes affecting many drugs Can cause GI intolerance and hepatotoxicity.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Loracarbef",
        "Drug Class": "Cephalosporin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Loratadine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "urticaria",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "No significant drug interactions at recommended doses Rarely may cause headache or somnolence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Lorazepam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Anxiety disorders",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "insomnia",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Losartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "diabetic nephropathy",
        "Contraindications": "Hyperkalemia",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lovastatin",
        "Drug Class": "Statin",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "myalgia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Luliconazole",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Cream",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin irritation",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lumefantrine",
        "Drug Class": "Antimalarial",
        "Indications": "Malaria (in combination)",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CYP3A4 inhibitors may increase levels and drugs that prolong QT interval are contraindicated Can cause QT prolongation and must be taken with food for absorption.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Not well studied; use only if benefit justifies risk",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Lurasidone",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar depression",
        "Contraindications": "Somnolence",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors and inducers are contraindicated Can cause somnolence and akathisia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Macitentan",
        "Drug Class": "Endothelin Receptor Antagonist",
        "Indications": "Pulmonary arterial hypertension (PAH)",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Anemia",
        "Contraindications": "nasopharyngitis",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Contraindicated in pregnancy due to fetal toxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Magaldrate",
        "Drug Class": "Antacid",
        "Indications": "Dyspepsia",
        "Dosage Form": "Suspension",
        "Strength": "480 mg/5 mL",
        "Route of Administration": "Oral",
        "Side Effects": "GERD",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Can decrease the absorption of many other drugs administer other drugs 2 hours before or after Can cause diarrhea or constipation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Generally considered safe in pregnancy",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Magnesium Hydroxide",
        "Drug Class": "Antacid / Laxative",
        "Indications": "Constipation",
        "Dosage Form": "Suspension",
        "Strength": "400 mg/5 mL",
        "Route of Administration": "Oral",
        "Side Effects": "dyspepsia",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Can decrease the absorption of many other drugs Can cause diarrhea and abdominal cramping.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Mannitol",
        "Drug Class": "Osmotic Diuretic",
        "Indications": "Reduced intracranial/intraocular pressure",
        "Dosage Form": "Solution",
        "Strength": "25%",
        "Route of Administration": "Intravenous",
        "Side Effects": "edema",
        "Contraindications": "Fluid and electrolyte imbalance",
        "Interaction warnings & Precautions": "Other diuretics may have additive effects Can cause fluid and electrolyte imbalances and pulmonary congestion.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Maprotiline",
        "Drug Class": "Tetracyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Can lower seizure threshold.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Maraviroc",
        "Drug Class": "CCR5 Antagonist",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Cough",
        "Contraindications": "fever",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors or inducers require dose adjustment Can cause hepatotoxicity and orthostatic hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mebendazole",
        "Drug Class": "Anthelmintic",
        "Indications": "Parasitic worm infections",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Abdominal pain",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Carbamazepine and phenytoin decrease mebendazole levels Can cause transaminase elevation and neutropenia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mecasermin",
        "Drug Class": "Recombinant Human IGF-1",
        "Indications": "Growth failure",
        "Dosage Form": "Solution",
        "Strength": "10 mg/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "injection site reactions",
        "Interaction warnings & Precautions": "Insulin and other hypoglycemic agents may increase risk Can cause hypoglycemia and require consumption of a meal or snack after administration.",
        "Storage Conditions": "Refrigerate Do Not Freeze",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Meclizine",
        "Drug Class": "Antihistamine",
        "Indications": "Vertigo",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "motion sickness",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects May cause drowsiness and impair mental and physical abilities.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Medroxyprogesterone",
        "Drug Class": "Progestin",
        "Indications": "Contraception",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "abnormal uterine bleeding",
        "Contraindications": "Weight gain",
        "Interaction warnings & Precautions": "Aminoglutethimide may decrease levels Can cause thromboembolic disorders and loss of bone mineral density.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mefenamic Acid",
        "Drug Class": "NSAID",
        "Indications": "Pain (including menstrual)",
        "Dosage Form": "Capsule",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dyspepsia",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mefloquine",
        "Drug Class": "Antimalarial",
        "Indications": "Malaria prevention and treatment",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Beta-blockers and other QT-prolonging agents may have additive effects Can cause severe neuropsychiatric reactions and vertigo.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Megestrol",
        "Drug Class": "Progestin",
        "Indications": "Appetite stimulant (cachexia)",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "breast cancer",
        "Contraindications": "Thromboembolism",
        "Interaction warnings & Precautions": "Can increase the effects of warfarin Can cause thromboembolic phenomena and adrenal suppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Meloxicam",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Tablet",
        "Strength": "7.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Melphalan",
        "Drug Class": "Alkylating Agent",
        "Indications": "Multiple myeloma",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "other cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and secondary malignancies.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Memantine",
        "Drug Class": "NMDA Receptor Antagonist",
        "Indications": "Alzheimer's disease",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "confusion",
        "Interaction warnings & Precautions": "Drugs that make urine alkaline (eg carbonic anhydrase inhibitors) may decrease excretion Generally well-tolerated with dizziness being the most common side effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Meperidine",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mercaptopurine",
        "Drug Class": "Antimetabolite",
        "Indications": "Leukemia",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Allopurinol inhibits xanthine oxidase increasing levels of active metabolites leading to severe myelosuppression Myelosuppression is dose-related and requires frequent CBC monitoring.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Meropenem",
        "Drug Class": "Carbapenem Antibiotic",
        "Indications": "Serious bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Valproic acid levels may be significantly reduced Can cause seizures and hypersensitivity reactions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mesalamine",
        "Drug Class": "5-ASA Derivative",
        "Indications": "Ulcerative colitis",
        "Dosage Form": "Tablet (DR)",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause renal impairment and acute intolerance syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mesna",
        "Drug Class": "Uroprotectant",
        "Indications": "Prevention of hemorrhagic cystitis",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "No significant drug interactions Used to prevent hemorrhagic cystitis caused by ifosfamide.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Metaxalone",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Muscle spasms",
        "Dosage Form": "Tablet",
        "Strength": "800 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Drowsiness",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause hemolytic anemia in patients with G6PD deficiency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Metformin",
        "Drug Class": "Biguanide",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methadone",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain management",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "opioid use disorder",
        "Contraindications": "Constipation",
        "Interaction warnings & Precautions": "CYP450 inducers or inhibitors can significantly alter levels Can cause QT prolongation and life-threatening respiratory depression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methimazole",
        "Drug Class": "Antithyroid Agent",
        "Indications": "Hyperthyroidism",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "arthralgia",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methocarbamol",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Muscle spasms",
        "Dosage Form": "Tablet",
        "Strength": "750 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Drowsiness",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause discoloration of urine.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methotrexate",
        "Drug Class": "Antimetabolite",
        "Indications": "Rheumatoid arthritis",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "certain cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "NSAIDs and probenecid can decrease renal excretion and increase levels Can cause myelosuppression and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methoxsalen",
        "Drug Class": "Psoralen",
        "Indications": "Psoriasis",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "vitiligo (with UVA)",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Many drugs are photosensitizing (eg tetracyclines) Can cause severe phototoxic reactions and increased risk of skin cancer.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methylcellulose",
        "Drug Class": "Bulk-Forming Laxative",
        "Indications": "Constipation",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bloating",
        "Contraindications": "flatulence",
        "Interaction warnings & Precautions": "Can decrease the absorption of other drugs administer other drugs at least 1 hour before or after Can cause esophageal obstruction if not taken with enough water.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Methyldopa",
        "Drug Class": "Centrally Acting Alpha-2 Agonist",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Lithium may cause increased lithium toxicity Can cause hemolytic anemia and positive Coombs test.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methylergonovine",
        "Drug Class": "Ergot Alkaloid",
        "Indications": "Prevent/treat postpartum hemorrhage",
        "Dosage Form": "Tablet",
        "Strength": "0.2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors are contraindicated due to risk of ergotism Contraindicated in hypertension and coronary artery disease.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methylnaltrexone",
        "Drug Class": "Peripheral Opioid Receptor Antagonist",
        "Indications": "Opioid-induced constipation",
        "Dosage Form": "Tablet",
        "Strength": "12 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Abdominal pain",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause abdominal pain and diarrhea.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methylphenidate",
        "Drug Class": "CNS Stimulant",
        "Indications": "ADHD",
        "Dosage Form": "Tablet (ER)",
        "Strength": "18 mg",
        "Route of Administration": "Oral",
        "Side Effects": "narcolepsy",
        "Contraindications": "Insomnia",
        "Interaction warnings & Precautions": "MAOIs are contraindicated due to risk of hypertensive crisis May exacerbate pre-existing psychosis and cause peripheral vasculopathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Methylprednisolone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression",
        "Contraindications": "Hyperglycemia",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Metoclopramide",
        "Drug Class": "Dopamine Antagonist",
        "Indications": "Gastroparesis",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "nausea/vomiting",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and tardive dyskinesia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Metolazone",
        "Drug Class": "Thiazide-like Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "edema",
        "Contraindications": "Hypokalemia",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause profound diuresis and electrolyte depletion.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Thiazide-like risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Metoprolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "heart failure",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Metronidazole",
        "Drug Class": "Nitroimidazole Antibiotic",
        "Indications": "Anaerobic bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "protozoal infections",
        "Contraindications": "Metallic taste",
        "Interaction warnings & Precautions": "Disulfiram-like reaction can occur with alcohol Can cause peripheral neuropathy and seizures with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Miconazole",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Cream",
        "Strength": "2%",
        "Route of Administration": "Topical",
        "Side Effects": "vaginal yeast infections",
        "Contraindications": "Skin irritation",
        "Interaction warnings & Precautions": "Warfarin metabolism is inhibited increasing INR For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Midazolam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Sedation",
        "Dosage Form": "Syrup",
        "Strength": "1 mg/mL",
        "Route of Administration": "Oral",
        "Side Effects": "anesthesia",
        "Contraindications": "anxiolysis",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Can cause profound respiratory depression and hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Midodrine",
        "Drug Class": "Alpha-1 Agonist",
        "Indications": "Orthostatic hypotension",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Supine hypertension",
        "Contraindications": "paresthesia",
        "Interaction warnings & Precautions": "Other vasoconstrictors can have additive effects Can cause supine hypertension and bradycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Miglitol",
        "Drug Class": "Alpha-Glucosidase Inhibitor",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Flatulence",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Can reduce the bioavailability of digoxin and propranolol Can cause flatulence diarrhea and abdominal pain.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Milrinone",
        "Drug Class": "Phosphodiesterase Inhibitor",
        "Indications": "Heart failure (short-term)",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Arrhythmias",
        "Contraindications": "hypotension",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause ventricular arrhythmias and hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Minocycline",
        "Drug Class": "Tetracycline Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "acne",
        "Contraindications": "Photosensitivity",
        "Interaction warnings & Precautions": "Antacids and calcium supplements decrease absorption Can cause photosensitivity and vestibular toxicity (dizziness vertigo).",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Tooth discoloration risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Minoxidil",
        "Drug Class": "Vasodilator / Hair Growth Stimulant",
        "Indications": "Hypertension",
        "Dosage Form": "Solution",
        "Strength": "5%",
        "Route of Administration": "Topical",
        "Side Effects": "androgenetic alopecia",
        "Contraindications": "Fluid retention",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Can cause pericardial effusion and hypertrichosis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Mirabegron",
        "Drug Class": "Beta-3 Adrenergic Agonist",
        "Indications": "Overactive bladder",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypertension",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors may increase levels Can increase blood pressure and cause urinary retention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mirtazapine",
        "Drug Class": "Tetracyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause significant weight gain and somnolence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Misoprostol",
        "Drug Class": "Prostaglandin Analog",
        "Indications": "Prevention of NSAID-induced ulcers",
        "Dosage Form": "Tablet",
        "Strength": "200 mcg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "abdominal pain",
        "Interaction warnings & Precautions": "No significant drug interactions Contraindicated in pregnancy due to abortifacient properties.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mitomycin",
        "Drug Class": "Antitumor Antibiotic",
        "Indications": "Various cancers",
        "Dosage Form": "Powder for Injection",
        "Strength": "5 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "mucositis",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and hemolytic uremic syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mitotane",
        "Drug Class": "Adrenolytic Agent",
        "Indications": "Adrenocortical carcinoma",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "CYP3A4 inducers may decrease efficacy Can cause adrenal insufficiency and neurotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mitoxantrone",
        "Drug Class": "Anthracenedione Antibiotic",
        "Indications": "Multiple sclerosis",
        "Dosage Form": "Solution",
        "Strength": "2 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "certain cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other cardiotoxic drugs increase risk Can cause severe myelosuppression and cardiotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Modafinil",
        "Drug Class": "CNS Stimulant",
        "Indications": "Narcolepsy",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "sleep apnea",
        "Contraindications": "shift work disorder",
        "Interaction warnings & Precautions": "Induces CYP3A4 and inhibits CYP2C19 affecting many drugs Can cause serious skin reactions and psychiatric symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mometasone",
        "Drug Class": "Topical / Inhaled Corticosteroid",
        "Indications": "Inflammatory skin conditions",
        "Dosage Form": "Cream",
        "Strength": "0.10%",
        "Route of Administration": "Topical",
        "Side Effects": "asthma",
        "Contraindications": "Skin atrophy",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase systemic exposure Systemic absorption can occur with extensive use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Montelukast",
        "Drug Class": "Leukotriene Receptor Antagonist",
        "Indications": "Asthma",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "allergic rhinitis",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Phenobarbital may decrease levels Can cause neuropsychiatric events including agitation and depression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Morphine",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet (ER)",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Moxifloxacin",
        "Drug Class": "Fluoroquinolone Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Drugs that prolong the QT interval may have additive effects Associated with tendonitis and tendon rupture and may exacerbate myasthenia gravis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Arthropathy risk in animals)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mupirocin",
        "Drug Class": "Antibiotic",
        "Indications": "Topical skin infections (impetigo)",
        "Dosage Form": "Ointment",
        "Strength": "2%",
        "Route of Administration": "Topical",
        "Side Effects": "Burning",
        "Contraindications": "itching",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Mycophenolate Mofetil",
        "Drug Class": "Immunosuppressant",
        "Indications": "Organ transplant rejection",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "autoimmune disorders",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Antacids and cholestyramine can decrease absorption Can cause severe myelosuppression and increased risk of infections.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nabumetone",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Tablet",
        "Strength": "750 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nadolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "Bradycardia",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nafcillin",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Warfarin metabolism is increased decreasing INR Can cause vein irritation and phlebitis with IV administration.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nalbuphine",
        "Drug Class": "Opioid Agonist-Antagonist",
        "Indications": "Pain",
        "Dosage Form": "Solution",
        "Strength": "10 mg/mL",
        "Route of Administration": "Intramuscular",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause withdrawal in patients dependent on other opioids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Naloxone",
        "Drug Class": "Opioid Antagonist",
        "Indications": "Opioid overdose",
        "Dosage Form": "Solution",
        "Strength": "0.4 mg/mL",
        "Route of Administration": "Intramuscular",
        "Side Effects": "Precipitated withdrawal",
        "Contraindications": "hypertension",
        "Interaction warnings & Precautions": "No significant drug interactions Can precipitate acute withdrawal in patients dependent on opioids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Naltrexone",
        "Drug Class": "Opioid Antagonist",
        "Indications": "Alcohol use disorder",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "opioid use disorder",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "No significant drug interactions Can precipitate acute withdrawal in patients dependent on opioids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Naproxen",
        "Drug Class": "NSAID",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "inflammation",
        "Contraindications": "dysmenorrhea",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Naratriptan",
        "Drug Class": "5-HT1 Agonist",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "drowsiness",
        "Interaction warnings & Precautions": "Other 5-HT1 agonists can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nateglinide",
        "Drug Class": "Meglitinide",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "120 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "weight gain",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nebivolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bradycardia",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Can cause bradycardia and heart failure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nefazodone",
        "Drug Class": "Serotonin Antagonist and Reuptake Inhibitor (SARI)",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and CYP3A4 inhibitors may increase levels Can cause rare but serious hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nelfinavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "625 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Induces and inhibits various CYP450 enzymes affecting many drugs Can cause diarrhea and rash.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Neomycin",
        "Drug Class": "Aminoglycoside Antibiotic",
        "Indications": "Hepatic encephalopathy",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "topical infections",
        "Contraindications": "Nephrotoxicity",
        "Interaction warnings & Precautions": "Other nephrotoxic or ototoxic drugs increase risk of toxicity Can cause ototoxicity and nephrotoxicity with systemic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Aminoglycoside risk of ototoxicity)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Neostigmine",
        "Drug Class": "Cholinesterase Inhibitor",
        "Indications": "Myasthenia gravis",
        "Dosage Form": "Tablet",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "reversal of neuromuscular blockade",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Other cholinergic agents can have additive effects Can cause bradycardia and bronchospasm.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nevirapine",
        "Drug Class": "NNRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "hepatotoxicity",
        "Interaction warnings & Precautions": "Induces CYP3A4 decreasing levels of many drugs Can cause severe skin reactions and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Niacin",
        "Drug Class": "Vitamin B3",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "niacin deficiency",
        "Contraindications": "Flushing",
        "Interaction warnings & Precautions": "Statins may increase risk of myopathy Can cause profound flushing and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Niacinamide",
        "Drug Class": "Vitamin B3",
        "Indications": "Niacin deficiency",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Pruritus",
        "Contraindications": "flushing",
        "Interaction warnings & Precautions": "No significant drug interactions Generally well-tolerated at recommended doses.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "Generally considered safe at recommended dietary amounts",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Nicardipine",
        "Drug Class": "Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors can significantly increase levels Can cause peripheral edema and reflex tachycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nifedipine",
        "Drug Class": "Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule (ER)",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "Peripheral edema",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors can significantly increase levels Can cause peripheral edema and reflex tachycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nilotinib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Chronic myeloid leukemia (CML)",
        "Dosage Form": "Capsule",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "QT prolongation",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause QT prolongation and sudden death.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nimodipine",
        "Drug Class": "Dihydropyridine CCB",
        "Indications": "Prevention of vasospasm after subarachnoid hemorrhage",
        "Dosage Form": "Capsule",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypotension",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors can significantly increase levels Must be administered orally via nasogastric tube if patient cannot swallow.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nisoldipine",
        "Drug Class": "Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet (ER)",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "peripheral edema",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors can significantly increase levels Can cause peripheral edema and reflex tachycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nitazoxanide",
        "Drug Class": "Antiprotozoal",
        "Indications": "Diarrhea caused by Cryptosporidium or Giardia",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Abdominal pain",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause abdominal pain and diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nitrofurantoin",
        "Drug Class": "Antibiotic",
        "Indications": "Uncomplicated UTIs",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "pulmonary fibrosis",
        "Interaction warnings & Precautions": "Antacids may decrease absorption Can cause pulmonary fibrosis and peripheral neuropathy with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nizatidine",
        "Drug Class": "H2 Blocker",
        "Indications": "Peptic ulcer disease",
        "Dosage Form": "Capsule",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GERD",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "No significant drug interactions May cause confusion more commonly in elderly or severely ill patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Norepinephrine",
        "Drug Class": "Alpha Agonist",
        "Indications": "Shock",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "hypotension",
        "Contraindications": "Tissue necrosis with extravasation",
        "Interaction warnings & Precautions": "MAOIs can cause severe hypertension Extravasation can cause tissue necrosis and sloughing.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Norethindrone",
        "Drug Class": "Progestin",
        "Indications": "Contraception",
        "Dosage Form": "Tablet",
        "Strength": "0.35 mg",
        "Route of Administration": "Oral",
        "Side Effects": "abnormal uterine bleeding",
        "Contraindications": "Breakthrough bleeding",
        "Interaction warnings & Precautions": "CYP3A4 inducers can decrease efficacy Can cause thromboembolic disorders.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Norgestimate-Ethinyl Estradiol",
        "Drug Class": "Progestin + Estrogen",
        "Indications": "Contraception",
        "Dosage Form": "Tablet",
        "Strength": "0.25/0.035 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg rifampin) can decrease efficacy and increase breakthrough bleeding Increases risk of thromboembolic disorders and stroke.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nortriptyline",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Capsule",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Nystatin",
        "Drug Class": "Antifungal",
        "Indications": "Fungal infections (oral",
        "Dosage Form": "000 unit/mL",
        "Strength": "100",
        "Route of Administration": "Suspension",
        "Side Effects": "cutaneous)",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "No significant drug interactions For topical or oral use only not for systemic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Oral"
    },
    {
        "Generic Name": "Obinutuzumab",
        "Drug Class": "Monoclonal Antibody",
        "Indications": "Chronic lymphocytic leukemia (CLL)",
        "Dosage Form": "Solution",
        "Strength": "1000 mg/40 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Infusion reactions",
        "Contraindications": "myelosuppression",
        "Interaction warnings & Precautions": "Hepatitis B virus reactivation can occur Can cause severe infusion reactions and tumor lysis syndrome.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "No data; potential for B-cell depletion in fetus",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ofloxacin",
        "Drug Class": "Fluoroquinolone Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "insomnia",
        "Interaction warnings & Precautions": "Chelates with divalent cations (antacids Ca2+ Fe2+) reducing absorption May enhance effects of warfarin Associated with tendonitis and tendon rupture.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Arthropathy risk in animals)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Olanzapine",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "Weight gain",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause metabolic changes including weight gain hyperlipidemia and hyperglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Olmesartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperkalemia",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Olodaterol",
        "Drug Class": "LABA",
        "Indications": "COPD",
        "Dosage Form": "Inhaler",
        "Strength": "2.5 mcg/actuation",
        "Route of Administration": "Inhalation",
        "Side Effects": "Headache",
        "Contraindications": "back pain",
        "Interaction warnings & Precautions": "Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Olopatadine",
        "Drug Class": "Antihistamine / Mast Cell Stabilizer",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Solution",
        "Strength": "0.20%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Headache",
        "Contraindications": "dry eyes",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only may cause mild transient burning or stinging.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Omeprazole",
        "Drug Class": "Proton Pump Inhibitor",
        "Indications": "GERD",
        "Dosage Form": "Capsule (DR)",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "erosive esophagitis",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required/Prescription"
    },
    {
        "Generic Name": "Ondansetron",
        "Drug Class": "5-HT3 Antagonist",
        "Indications": "Chemotherapy-induced nausea/vomiting",
        "Dosage Form": "Tablet",
        "Strength": "8 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Drugs that prolong the QT interval may have additive effects Can cause QT prolongation and subsequent arrhythmias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Orlistat",
        "Drug Class": "Lipase Inhibitor",
        "Indications": "Obesity management",
        "Dosage Form": "Capsule",
        "Strength": "60 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Oily spotting",
        "Contraindications": "flatus with discharge",
        "Interaction warnings & Precautions": "Can reduce absorption of fat-soluble vitamins (A D E K) Can cause steatorrhea and fecal incontinence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Orphenadrine",
        "Drug Class": "Skeletal Muscle Relaxant",
        "Indications": "Muscle spasms",
        "Dosage Form": "Tablet (ER)",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "blurred vision",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause drowsiness and dry mouth.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oseltamivir",
        "Drug Class": "Neuraminidase Inhibitor",
        "Indications": "Influenza",
        "Dosage Form": "Capsule",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "No significant drug interactions May cause nausea and vomiting and rare neuropsychiatric events.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxacillin",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxaliplatin",
        "Drug Class": "Alkylating Agent",
        "Indications": "Colorectal cancer",
        "Dosage Form": "Solution",
        "Strength": "5 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Neurotoxicity",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other nephrotoxic drugs may enhance platinum-induced renal toxicity Can cause peripheral sensory neuropathy and pharyngolaryngeal dysesthesia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxaprozin",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxazepam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Anxiety disorders",
        "Dosage Form": "Capsule",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "alcohol withdrawal",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxcarbazepine",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "diplopia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease levels of active metabolite Can cause hyponatremia and cross-hypersensitivity with carbamazepine.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxybutynin",
        "Drug Class": "Anticholinergic",
        "Indications": "Overactive bladder",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause blurred vision and urinary retention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxycodone",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Oxymetazoline",
        "Drug Class": "Alpha Agonist",
        "Indications": "Nasal congestion",
        "Dosage Form": "Spray",
        "Strength": "0.05%",
        "Route of Administration": "Nasal",
        "Side Effects": "Rebound congestion",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "MAOIs can cause hypertensive crisis Can cause rebound congestion (rhinitis medicamentosa) with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Oxytetracycline",
        "Drug Class": "Tetracycline Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Photosensitivity",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Antacids and calcium supplements decrease absorption Can cause photosensitivity and tooth discoloration.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Tooth discoloration risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Paclitaxel",
        "Drug Class": "Antimicrotubule Agent",
        "Indications": "Ovarian cancer",
        "Dosage Form": "Solution",
        "Strength": "6 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "breast cancer",
        "Contraindications": "other cancers",
        "Interaction warnings & Precautions": "Strong CYP3A4 or CYP2C8 inhibitors may increase levels Can cause severe hypersensitivity reactions myelosuppression and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Palbociclib",
        "Drug Class": "CDK4/6 Inhibitor",
        "Indications": "Breast cancer",
        "Dosage Form": "Capsule",
        "Strength": "125 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause severe neutropenia and pulmonary embolism.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "No data; based on mechanism likely D",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Paliperidone",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet (ER)",
        "Strength": "3 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Weight gain",
        "Contraindications": "tachycardia",
        "Interaction warnings & Precautions": "Strong CYP3A4 or P-gp inducers may decrease levels Can cause QT prolongation and orthostatic hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Palonosetron",
        "Drug Class": "5-HT3 Antagonist",
        "Indications": "Chemotherapy-induced nausea/vomiting",
        "Dosage Form": "Solution",
        "Strength": "0.25 mg/5 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Headache",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "No significant drug interactions Generally well-tolerated with constipation being the most common side effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pamidronate",
        "Drug Class": "Bisphosphonate",
        "Indications": "Hypercalcemia of malignancy",
        "Dosage Form": "Solution",
        "Strength": "90 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "bone metastases",
        "Contraindications": "Flu-like symptoms",
        "Interaction warnings & Precautions": "Nephrotoxic drugs may increase risk of renal impairment Can cause renal impairment and hypocalcemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pantoprazole",
        "Drug Class": "Proton Pump Inhibitor",
        "Indications": "GERD",
        "Dosage Form": "Tablet (DR)",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "erosive esophagitis",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Papaverine",
        "Drug Class": "Vasodilator",
        "Indications": "Visceral spasm",
        "Dosage Form": "Tablet (ER)",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "sometimes erectile dysfunction",
        "Contraindications": "Hypotension",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause hepatic hypersensitivity with elevated LFTs.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Paromomycin",
        "Drug Class": "Aminoglycoside Antibiotic",
        "Indications": "Intestinal amebiasis",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other nephrotoxic or ototoxic drugs increase risk of toxicity Used for intestinal amebiasis not systemic infections.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Paroxetine",
        "Drug Class": "SSRI",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "anxiety disorders",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and strong inhibitors of CYP2D6 may increase levels May increase risk of bleeding especially with NSAIDs or warfarin.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Cardiac risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pazopanib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Renal cell carcinoma",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "soft tissue sarcoma",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hepatotoxicity and QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pegfilgrastim",
        "Drug Class": "G-CSF Analog",
        "Indications": "Chemotherapy-induced neutropenia",
        "Dosage Form": "Solution",
        "Strength": "6 mg/0.6 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Bone pain",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause bone pain and splenic rupture.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Peginterferon Alfa-2a",
        "Drug Class": "Immunomodulator",
        "Indications": "Hepatitis B/C",
        "Dosage Form": "Solution",
        "Strength": "180 mcg/1 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Psychiatric effects",
        "Contraindications": "flu-like symptoms",
        "Interaction warnings & Precautions": "Theophylline clearance may be decreased Can cause severe psychiatric effects myelosuppression and autoimmunity.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pegloticase",
        "Drug Class": "Urate Oxidase Enzyme",
        "Indications": "Refractory gout",
        "Dosage Form": "Solution",
        "Strength": "8 mg/1 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Infusion reactions",
        "Contraindications": "gout flares",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause severe infusion reactions and anaphylaxis.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pembrolizumab",
        "Drug Class": "PD-1 Inhibitor",
        "Indications": "Various cancers",
        "Dosage Form": "Solution",
        "Strength": "100 mg/4 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Fatigue",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause immune-mediated adverse reactions affecting any organ system.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; potential for immune-mediated disorders in fetus",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pemirolast",
        "Drug Class": "Mast Cell Stabilizer",
        "Indications": "Allergic conjunctivitis",
        "Dosage Form": "Solution",
        "Strength": "0.10%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Headache",
        "Contraindications": "dry eyes",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only may cause headache or rhinitis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Penciclovir",
        "Drug Class": "Antiviral",
        "Indications": "Herpes labialis (cold sores)",
        "Dosage Form": "Cream",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "Application site reaction",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic or oral use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Penicillin G",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "5 million unit",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Penicillin V",
        "Drug Class": "Penicillin Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion Serious and occasionally fatal hypersensitivity reactions have been reported.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pentamidine",
        "Drug Class": "Antiprotozoal",
        "Indications": "Pneumocystis jirovecii pneumonia (PCP)",
        "Dosage Form": "Powder for Injection",
        "Strength": "300 mg",
        "Route of Administration": "Inhalation",
        "Side Effects": "Hypotension",
        "Contraindications": "hypoglycemia",
        "Interaction warnings & Precautions": "Other nephrotoxic drugs increase risk of toxicity Can cause severe hypotension hypoglycemia and nephrotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pentazocine",
        "Drug Class": "Opioid Agonist-Antagonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause withdrawal in patients dependent on other opioids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pentobarbital",
        "Drug Class": "Barbiturate",
        "Indications": "Sedation",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "insomnia",
        "Contraindications": "seizures",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause respiratory depression and dependence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pentosan",
        "Drug Class": "Urinary Analgesic",
        "Indications": "Interstitial cystitis",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Alopecia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other anticoagulants may increase bleeding risk Can cause bleeding and alopecia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pentoxifylline",
        "Drug Class": "Xanthine Derivative",
        "Indications": "Intermittent claudication",
        "Dosage Form": "Tablet (ER)",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "dyspepsia",
        "Interaction warnings & Precautions": "Antihypertensive drugs may have additive effects Can cause nausea and dizziness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Perampanel",
        "Drug Class": "AMPA Receptor Antagonist",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can cause serious neuropsychiatric events including aggression and hostility.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Perindopril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Permethrin",
        "Drug Class": "Scabicidal / Pediculicidal",
        "Indications": "Scabies",
        "Dosage Form": "Cream",
        "Strength": "5%",
        "Route of Administration": "Topical",
        "Side Effects": "lice",
        "Contraindications": "Pruritus",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only if ingestion occurs can cause CNS effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Perphenazine",
        "Drug Class": "Typical Antipsychotic",
        "Indications": "Psychotic disorders",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Extrapyramidal symptoms",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Phenazopyridine",
        "Drug Class": "Urinary Analgesic",
        "Indications": "Urinary tract pain",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI upset",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause red-orange discoloration of urine and may stain clothing.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Phenelzine",
        "Drug Class": "MAOI",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Orthostatic hypotension",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "Tyramine-containing foods and serotonergic drugs can cause hypertensive crisis and serotonin syndrome Requires strict dietary restrictions to prevent hypertensive crisis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Phenobarbital",
        "Drug Class": "Barbiturate",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "sedation",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "Induces CYP450 enzymes reducing levels of many drugs (eg oral contraceptives warfarin) Can cause respiratory depression and dependence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Phentermine",
        "Drug Class": "Sympathomimetic Amine",
        "Indications": "Obesity (short-term)",
        "Dosage Form": "Tablet",
        "Strength": "37.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Insomnia",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "MAOIs can cause hypertensive crisis High potential for abuse and dependence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Phenytoin",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Gingival hyperplasia",
        "Contraindications": "nystagmus",
        "Interaction warnings & Precautions": "Many drugs can increase or decrease phenytoin levels Can cause life-threatening dermatologic reactions like Stevens-Johnson syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Fetal hydantoin syndrome risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pilocarpine",
        "Drug Class": "Cholinergic",
        "Indications": "Glaucoma",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "xerostomia",
        "Contraindications": "Sweating",
        "Interaction warnings & Precautions": "Other cholinergic agents can have additive effects Can cause blurred vision and sweating.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pimavanserin",
        "Drug Class": "Serotonin Inverse Agonist",
        "Indications": "Parkinson's disease psychosis",
        "Dosage Form": "Capsule",
        "Strength": "34 mg",
        "Route of Administration": "Oral",
        "Side Effects": "QT prolongation",
        "Contraindications": "peripheral edema",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can prolong the QT interval.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pimecrolimus",
        "Drug Class": "Calcineurin Inhibitor",
        "Indications": "Atopic dermatitis",
        "Dosage Form": "Cream",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "Burning",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions May increase risk of skin malignancies and lymphomas.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pimozide",
        "Drug Class": "Typical Antipsychotic",
        "Indications": "Tourette's syndrome",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Extrapyramidal symptoms",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors are contraindicated due to risk of QT prolongation Can cause QT prolongation and extrapyramidal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pindolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bradycardia",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pioglitazone",
        "Drug Class": "Thiazolidinedione",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "30 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Weight gain",
        "Contraindications": "edema",
        "Interaction warnings & Precautions": "Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and bladder cancer.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Piperacillin-Tazobactam",
        "Drug Class": "Penicillin Antibiotic + Beta-Lactamase Inhibitor",
        "Indications": "Serious bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "3.375 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion May cause diarrhea including Clostridium difficile-associated diarrhea.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pirbuterol",
        "Drug Class": "SABA",
        "Indications": "Asthma",
        "Dosage Form": "Inhaler",
        "Strength": "0.4 mg/actuation",
        "Route of Administration": "Inhalation",
        "Side Effects": "bronchospasm",
        "Contraindications": "Tachycardia",
        "Interaction warnings & Precautions": "Beta-blockers may antagonize the effects Can cause paradoxical bronchospasm and cardiovascular effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Piroxicam",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Capsule",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pitavastatin",
        "Drug Class": "Statin",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "myalgia",
        "Interaction warnings & Precautions": "Cyclosporine may increase levels Can cause myopathy and rhabdomyolysis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pramipexole",
        "Drug Class": "Dopamine Agonist",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "0.25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "restless legs syndrome",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Other CNS depressants may enhance sedative effects Can cause somnolence and impulse control disorders.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pramlintide",
        "Drug Class": "Amylin Analog",
        "Indications": "Type 1 & 2 diabetes (adjunct)",
        "Dosage Form": "Solution",
        "Strength": "0.6 mg/0.1 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Nausea",
        "Contraindications": "hypoglycemia",
        "Interaction warnings & Precautions": "Other drugs that affect GI motility may have additive effects Can cause severe hypoglycemia especially when used with insulin.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Prasugrel",
        "Drug Class": "Antiplatelet",
        "Indications": "Acute coronary syndrome",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bleeding",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Contraindicated in patients with history of stroke or TIA.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pravastatin",
        "Drug Class": "Statin",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "myalgia",
        "Interaction warnings & Precautions": "Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Praziquantel",
        "Drug Class": "Anthelmintic",
        "Indications": "Schistosomiasis",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "other fluke infections",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "CYP450 inducers like carbamazepine can decrease levels Can cause abdominal discomfort and dizziness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Prazosin",
        "Drug Class": "Alpha-1 Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "BPH",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Prednisolone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression",
        "Contraindications": "Hyperglycemia",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Prednisone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression",
        "Contraindications": "Hyperglycemia",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pregabalin",
        "Drug Class": "Anticonvulsant",
        "Indications": "Neuropathic pain",
        "Dosage Form": "Capsule",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "seizures",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause angioedema and withdrawal symptoms upon discontinuation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Primaquine",
        "Drug Class": "Antimalarial",
        "Indications": "Malaria (radical cure for P. vivax/ovale)",
        "Dosage Form": "Tablet",
        "Strength": "26.3 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI upset",
        "Contraindications": "hemolytic anemia in G6PD deficiency",
        "Interaction warnings & Precautions": "Other drugs that cause hemolysis or depress myeloid function can have additive effects Can cause hemolytic anemia in patients with G6PD deficiency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "Not recommended; can cause hemolysis in G6PD deficiency",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Primidone",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "ataxia",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause sedation and megaloblastic anemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Probenecid",
        "Drug Class": "Uricosuric",
        "Indications": "Gout",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperuricemia",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Increases levels of many drugs by inhibiting their renal secretion (eg penicillins methotrexate) Can cause GI upset and nephrotic syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Procainamide",
        "Drug Class": "Antiarrhythmic (Class Ia)",
        "Indications": "Ventricular arrhythmias",
        "Dosage Form": "Tablet (CR)",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Lupus-like syndrome",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause lupus-like syndrome and blood dyscrasias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Prochlorperazine",
        "Drug Class": "Typical Antipsychotic / Antiemetic",
        "Indications": "Psychotic disorders",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "nausea/vomiting",
        "Contraindications": "Extrapyramidal symptoms",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Progesterone",
        "Drug Class": "Progestin",
        "Indications": "Hormone replacement",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "abnormal uterine bleeding",
        "Contraindications": "Drowsiness",
        "Interaction warnings & Precautions": "CYP3A4 inducers can decrease efficacy Can cause thromboembolic disorders.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Promethazine",
        "Drug Class": "Antihistamine / Antiemetic",
        "Indications": "Allergic reactions",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "nausea/vomiting",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause respiratory depression in children and extrapyramidal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Propafenone",
        "Drug Class": "Antiarrhythmic (Class Ic)",
        "Indications": "Ventricular arrhythmias",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "atrial fibrillation",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors may increase levels Can cause new or worsened arrhythmias and bronchospasm in patients with asthma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Propantheline",
        "Drug Class": "Anticholinergic",
        "Indications": "Peptic ulcer disease",
        "Dosage Form": "Tablet",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI spasms",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Contraindicated in patients with glaucoma or severe ulcerative colitis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Propofol",
        "Drug Class": "General Anesthetic",
        "Indications": "Induction/maintenance of anesthesia",
        "Dosage Form": "Emulsion",
        "Strength": "10 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Respiratory depression",
        "Contraindications": "hypotension",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause profound respiratory depression and hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Propranolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "migraine prevention",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Abrupt withdrawal may exacerbate angina pectoris or cause myocardial infarction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Propylthiouracil",
        "Drug Class": "Antithyroid Agent",
        "Indications": "Hyperthyroidism",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "arthralgia",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Protamine",
        "Drug Class": "Antidote",
        "Indications": "Reversal of heparin anticoagulation",
        "Dosage Form": "Solution",
        "Strength": "10 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Hypotension",
        "Contraindications": "bradycardia",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause severe hypotension and anaphylaxis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pseudoephedrine",
        "Drug Class": "Sympathomimetic",
        "Indications": "Nasal congestion",
        "Dosage Form": "Tablet",
        "Strength": "60 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Insomnia",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "MAOIs can cause hypertensive crisis Can cause insomnia and tachycardia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Pyrazinamide",
        "Drug Class": "Antimycobacterial",
        "Indications": "Tuberculosis",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hepatotoxicity",
        "Contraindications": "hyperuricemia",
        "Interaction warnings & Precautions": "May increase uric acid levels Can cause hepatotoxicity and hyperuricemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pyridostigmine",
        "Drug Class": "Cholinesterase Inhibitor",
        "Indications": "Myasthenia gravis",
        "Dosage Form": "Tablet",
        "Strength": "60 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "salivation",
        "Interaction warnings & Precautions": "Other cholinergic agents can have additive effects Can cause bradycardia and bronchospasm.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Pyrimethamine",
        "Drug Class": "Antimalarial / Antiprotozoal",
        "Indications": "Malaria",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "toxoplasmosis",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Other drugs that cause folate deficiency can have additive effects Can cause megaloblastic anemia and blood dyscrasias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Quetiapine",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "Somnolence",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause sedation cataracts and metabolic changes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Quinapril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Quinidine",
        "Drug Class": "Antiarrhythmic (Class Ia)",
        "Indications": "Atrial fibrillation/flutter",
        "Dosage Form": "Tablet (ER)",
        "Strength": "324 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI upset",
        "Contraindications": "cinchonism",
        "Interaction warnings & Precautions": "Inhibits CYP2D6 and CYP3A4 increasing levels of many drugs Can cause cinchonism and thrombocytopenia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Quinine",
        "Drug Class": "Antimalarial",
        "Indications": "Malaria (chloroquine-resistant)",
        "Dosage Form": "Tablet",
        "Strength": "324 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Cinchonism (tinnitus",
        "Contraindications": "headache)",
        "Interaction warnings & Precautions": "Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause cinchonism and blackwater fever.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rabeprazole",
        "Drug Class": "Proton Pump Inhibitor",
        "Indications": "GERD",
        "Dosage Form": "Tablet (DR)",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "erosive esophagitis",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Raloxifene",
        "Drug Class": "SERM",
        "Indications": "Osteoporosis prevention/treatment in postmenopausal women",
        "Dosage Form": "Tablet",
        "Strength": "60 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "leg cramps",
        "Interaction warnings & Precautions": "Cholestyramine may decrease absorption Increases risk of thromboembolic events and fatal stroke.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Raltegravir",
        "Drug Class": "Integrase Strand Transfer Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "insomnia",
        "Interaction warnings & Precautions": "Strong UGT1A1 inducers may decrease levels Can cause severe and potentially fatal skin reactions.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ramipril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "diabetic nephropathy",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ranitidine",
        "Drug Class": "H2 Blocker",
        "Indications": "Peptic ulcer disease",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GERD",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "No significant drug interactions May cause confusion more commonly in elderly or severely ill patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Rasagiline",
        "Drug Class": "MAOI",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other MAOIs and sympathomimetics can cause hypertensive crisis Can cause hypertensive crisis if tyramine-rich foods are consumed.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rasburicase",
        "Drug Class": "Urate Oxidase Enzyme",
        "Indications": "Tumor lysis syndrome",
        "Dosage Form": "Powder for Injection",
        "Strength": "1.5 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Hyperensitivity",
        "Contraindications": "hemolysis",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause severe hypersensitivity reactions and hemolysis in patients with G6PD deficiency.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Regorafenib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Colorectal cancer",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GIST",
        "Contraindications": "Fatigue",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause severe hepatotoxicity and hemorrhage.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Remdesivir",
        "Drug Class": "Antiviral",
        "Indications": "COVID-19",
        "Dosage Form": "Powder for Injection",
        "Strength": "100 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nausea",
        "Contraindications": "elevated LFTs",
        "Interaction warnings & Precautions": "No significant drug interactions Not recommended in patients with eGFR < 30 mL/min.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; use only if potential benefit justifies risk",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Reserpine",
        "Drug Class": "Antiaderenergic",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "0.1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Depression",
        "Contraindications": "nasal congestion",
        "Interaction warnings & Precautions": "MAOIs can cause excitability and hypertension Can cause depression and suicidal ideation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Retapamulin",
        "Drug Class": "Antibiotic",
        "Indications": "Impetigo",
        "Dosage Form": "Ointment",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "Application site irritation",
        "Contraindications": "pruritus",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for oral or ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ribavirin",
        "Drug Class": "Antiviral",
        "Indications": "Hepatitis C",
        "Dosage Form": "Capsule",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "RSV infection",
        "Contraindications": "Hemolytic anemia",
        "Interaction warnings & Precautions": "Interferon alfa may increase toxicity Highly teratogenic and embryocidal requires strict pregnancy prevention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rifabutin",
        "Drug Class": "Antimycobacterial",
        "Indications": "Mycobacterium avium complex (MAC) prophylaxis",
        "Dosage Form": "Capsule",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Neutropenia",
        "Contraindications": "uveitis",
        "Interaction warnings & Precautions": "Induces CYP3A4 decreasing levels of many drugs Can cause uveitis and neutropenia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rifampin",
        "Drug Class": "Antimycobacterial",
        "Indications": "Tuberculosis",
        "Dosage Form": "Capsule",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hepatotoxicity",
        "Contraindications": "orange discoloration of bodily fluids",
        "Interaction warnings & Precautions": "A strong inducer of CYP450 enzymes decreasing levels of many drugs Can cause hepatotoxicity and orange discoloration of bodily fluids.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rifapentine",
        "Drug Class": "Antimycobacterial",
        "Indications": "Tuberculosis",
        "Dosage Form": "Tablet",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperuricemia",
        "Contraindications": "pyuria",
        "Interaction warnings & Precautions": "Induces CYP3A4 and CYP2C8/9 decreasing levels of many drugs Can cause hepatotoxicity and hyperuricemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; likely C",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rifaximin",
        "Drug Class": "Antibiotic",
        "Indications": "Traveler's diarrhea",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hepatic encephalopathy",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "No significant drug interactions For travelers' diarrhea and hepatic encephalopathy not systemic infections.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rilpivirine",
        "Drug Class": "NNRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Depression",
        "Contraindications": "insomnia",
        "Interaction warnings & Precautions": "Proton pump inhibitors are contraindicated as they significantly decrease levels Can cause depressive disorders and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Riluzole",
        "Drug Class": "Glutamate Inhibitor",
        "Indications": "Amyotrophic lateral sclerosis (ALS)",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Strong CYP1A2 inhibitors may increase levels Can cause elevated liver enzymes and neutropenia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rimantadine",
        "Drug Class": "Antiviral",
        "Indications": "Influenza A",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Insomnia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Acetaminophen and aspirin may decrease rimantadine levels Can cause CNS side effects like insomnia and dizziness.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Risedronate",
        "Drug Class": "Bisphosphonate",
        "Indications": "Osteoporosis",
        "Dosage Form": "Tablet",
        "Strength": "35 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Paget's disease",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "Calcium supplements and other oral medications can interfere with absorption Risk of esophageal irritation and osteonecrosis of the jaw.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Risperidone",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "Weight gain",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors may increase levels Can cause hyperprolactinemia and metabolic changes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ritonavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection (often as booster)",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "A strong inhibitor of CYP3A4 affecting many drugs Can cause GI intolerance hepatotoxicity and pancreatitis.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rivaroxaban",
        "Drug Class": "Direct Oral Anticoagulant (Factor Xa Inhibitor)",
        "Indications": "Stroke prevention in atrial fibrillation",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "VTE treatment",
        "Contraindications": "Bleeding",
        "Interaction warnings & Precautions": "Strong dual inducers of CYP3A4 and P-gp decrease levels increasing stroke risk Risk of serious and fatal bleeding discontinue if active bleeding occurs.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Risk of hemorrhage)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rivastigmine",
        "Drug Class": "Cholinesterase Inhibitor",
        "Indications": "Alzheimer's disease",
        "Dosage Form": "Capsule",
        "Strength": "4.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Parkinson's disease dementia",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Other cholinergic agents can have additive effects Can cause nausea vomiting and weight loss.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rizatriptan",
        "Drug Class": "5-HT1 Agonist",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "drowsiness",
        "Interaction warnings & Precautions": "MAOIs and other 5-HT1 agonists can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ropinirole",
        "Drug Class": "Dopamine Agonist",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "restless legs syndrome",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "CYP1A2 inhibitors may increase levels Can cause somnolence and impulse control disorders.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ropivacaine",
        "Drug Class": "Local Anesthetic",
        "Indications": "Local / regional anesthesia",
        "Dosage Form": "Solution",
        "Strength": "2 mg/mL",
        "Route of Administration": "Injection",
        "Side Effects": "Hypotension",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other local anesthetics or drugs that cause methemoglobinemia can have additive effects Can cause CNS toxicity and methemoglobinemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rosiglitazone",
        "Drug Class": "Thiazolidinedione",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Ooral",
        "Side Effects": "Weight gain",
        "Contraindications": "edema",
        "Interaction warnings & Precautions": "Strong CYP2C8 inhibitors may increase levels Can cause or exacerbate congestive heart failure and myocardial ischemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rosuvastatin",
        "Drug Class": "Statin",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "myalgia",
        "Interaction warnings & Precautions": "Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Rotigotine",
        "Drug Class": "Dopamine Agonist",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Patch",
        "Strength": "2 mg/24 hr",
        "Route of Administration": "Transdermal",
        "Side Effects": "restless legs syndrome",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "CYP450 inhibitors are unlikely to significantly affect levels due to transdermal administration Can cause application site reactions and impulse control disorders.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ruxolitinib",
        "Drug Class": "JAK Inhibitor",
        "Indications": "Myelofibrosis",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "polycythemia vera",
        "Contraindications": "Thrombocytopenia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause serious infections and myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sacubitril-Valsartan",
        "Drug Class": "ARNI",
        "Indications": "Heart failure",
        "Dosage Form": "Tablet",
        "Strength": "24/26 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperkalemia",
        "Contraindications": "hypotension",
        "Interaction warnings & Precautions": "ACE inhibitors are contraindicated due to increased risk of angioedema Can cause angioedema and hyperkalemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB/ARNI risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Salicylic Acid",
        "Drug Class": "Keratolytic",
        "Indications": "Psoriasis",
        "Dosage Form": "Solution",
        "Strength": "6%",
        "Route of Administration": "Topical",
        "Side Effects": "warts",
        "Contraindications": "acne",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only excessive use can lead to salicylism.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Salmeterol",
        "Drug Class": "LABA",
        "Indications": "Asthma",
        "Dosage Form": "Inhaler",
        "Strength": "50 mcg/actuation",
        "Route of Administration": "Inhalation",
        "Side Effects": "COPD",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Other adrenergic drugs can have additive cardiovascular effects Can cause paradoxical bronchospasm and increase the risk of asthma-related death.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Saquinavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause GI intolerance and hepatotoxicity.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Saxagliptin",
        "Drug Class": "DPP-4 Inhibitor",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nasopharyngitis",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Strong CYP3A4/5 inhibitors may increase levels May cause hypersensitivity reactions including anaphylaxis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Scopolamine",
        "Drug Class": "Anticholinergic",
        "Indications": "Motion sickness",
        "Dosage Form": "Patch",
        "Strength": "1 mg/72 hr",
        "Route of Administration": "Transdermal",
        "Side Effects": "nausea",
        "Contraindications": "Dry mouth",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause drowsiness and confusion.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Secobarbital",
        "Drug Class": "Barbiturate",
        "Indications": "Insomnia",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause respiratory depression and dependence.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Selegiline",
        "Drug Class": "MAOI",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other MAOIs and sympathomimetics can cause hypertensive crisis Can cause hypertensive crisis if tyramine-rich foods are consumed in high doses.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Selenium Sulfide",
        "Drug Class": "Antifungal / Antiseborrheic",
        "Indications": "Dandruff",
        "Dosage Form": "Lotion",
        "Strength": "2.50%",
        "Route of Administration": "Topical",
        "Side Effects": "seborrheic dermatitis",
        "Contraindications": "Hair discoloration",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only can cause hair discoloration.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Sertaconazole",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Cream",
        "Strength": "2%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin irritation",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sertraline",
        "Drug Class": "SSRI",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "anxiety disorders",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and CYP2D6 inhibitors may increase levels May increase risk of bleeding especially with NSAIDs or warfarin.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sevelamer",
        "Drug Class": "Phosphate Binder",
        "Indications": "Hyperphosphatemia in CKD",
        "Dosage Form": "Tablet",
        "Strength": "800 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Can decrease the absorption of many other drugs administer other drugs 1 hour before or 3 hours after Can cause GI side effects and hypocalcemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sildenafil",
        "Drug Class": "PDE5 Inhibitor",
        "Indications": "Erectile dysfunction",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "PAH",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Nitrates can cause severe hypotension Can cause priapism and sudden hearing loss.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Silodosin",
        "Drug Class": "Alpha-1 Blocker",
        "Indications": "BPH",
        "Dosage Form": "Capsule",
        "Strength": "8 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Retrograde ejaculation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Can cause retrograde ejaculation and orthostatic hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; not indicated for use in women",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Simeprevir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "Hepatitis C",
        "Dosage Form": "Capsule",
        "Strength": "150 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "photosensitivity",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause photosensitivity and rash.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; use only if benefit justifies risk",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Simvastatin",
        "Drug Class": "Statin",
        "Indications": "Hyperlipidemia",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "myalgia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sirolimus",
        "Drug Class": "Immunosuppressant",
        "Indications": "Organ transplant rejection",
        "Dosage Form": "Tablet",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Stomatitis",
        "Contraindications": "hyperlipidemia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hyperlipidemia and immunosuppression.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sitagliptin",
        "Drug Class": "DPP-4 Inhibitor",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nasopharyngitis",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions May cause hypersensitivity reactions including anaphylaxis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sodium Bicarbonate",
        "Drug Class": "Alkalinizing Agent",
        "Indications": "Metabolic acidosis",
        "Dosage Form": "Tablet",
        "Strength": "650 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hyperkalemia",
        "Contraindications": "Alkalosis",
        "Interaction warnings & Precautions": "Can decrease the levels of many drugs by increasing urinary pH Can cause metabolic alkalosis and fluid overload.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Sodium Chloride",
        "Drug Class": "Electrolyte",
        "Indications": "Hyponatremia",
        "Dosage Form": "Solution",
        "Strength": "0.90%",
        "Route of Administration": "Intravenous",
        "Side Effects": "fluid replacement",
        "Contraindications": "Fluid overload",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause hypernatremia and fluid overload.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sodium Oxybate",
        "Drug Class": "CNS Depressant",
        "Indications": "Cataplexy",
        "Dosage Form": "Solution",
        "Strength": "500 mg/mL",
        "Route of Administration": "Oral",
        "Side Effects": "excessive daytime sleepiness in narcolepsy",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol can cause profound sedation and respiratory depression Can cause sleepwalking and respiratory depression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sodium Phenylbutyrate",
        "Drug Class": "Urea Cycle Disorder Agent",
        "Indications": "Urea cycle disorders",
        "Dosage Form": "Powder",
        "Strength": "3 g",
        "Route of Administration": "Oral",
        "Side Effects": "Amenorrhea",
        "Contraindications": "body odor",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause body odor and menstrual irregularities.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sofosbuvir",
        "Drug Class": "NS5B Polymerase Inhibitor",
        "Indications": "Hepatitis C",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Fatigue",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "Strong P-gp inducers may decrease levels Generally well-tolerated with fatigue and headache being common.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; use with ribavirin is X",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Solifenacin",
        "Drug Class": "Anticholinergic",
        "Indications": "Overactive bladder",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause blurred vision and urinary retention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Somatropin",
        "Drug Class": "Growth Hormone",
        "Indications": "Growth hormone deficiency",
        "Dosage Form": "Solution",
        "Strength": "5 mg",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Injection site reactions",
        "Contraindications": "edema",
        "Interaction warnings & Precautions": "Glucocorticoids may inhibit the growth-promoting effects Can cause glucose intolerance and slipped capital femoral epiphysis in children.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sorafenib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Renal cell carcinoma",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Ooral",
        "Side Effects": "hepatocellular carcinoma",
        "Contraindications": "Hand-foot skin reaction",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can cause hand-foot skin reaction and hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sotalol",
        "Drug Class": "Antiarrhythmic (Class III)",
        "Indications": "Ventricular arrhythmias",
        "Dosage Form": "Tablet",
        "Strength": "80 mg",
        "Route of Administration": "Oral",
        "Side Effects": "atrial fibrillation",
        "Contraindications": "Fatigue",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or prolong QT interval can have additive effects Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Spironolactone",
        "Drug Class": "Aldosterone Antagonist",
        "Indications": "Heart failure",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hypertension",
        "Contraindications": "hyperaldosteronism",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may increase risk of hyperkalemia Can cause hyperkalemia and gynecomastia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Stavudine",
        "Drug Class": "NRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Capsule",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Peripheral neuropathy",
        "Contraindications": "pancreatitis",
        "Interaction warnings & Precautions": "Other drugs that cause peripheral neuropathy or pancreatitis increase risk Can cause peripheral neuropathy and pancreatitis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Streptomycin",
        "Drug Class": "Aminoglycoside Antibiotic",
        "Indications": "Tuberculosis",
        "Dosage Form": "Powder for Injection",
        "Strength": "1 g",
        "Route of Administration": "Intramuscular",
        "Side Effects": "Ototoxicity",
        "Contraindications": "nephrotoxicity",
        "Interaction warnings & Precautions": "Other nephrotoxic or ototoxic drugs increase risk of toxicity Can cause ototoxicity and nephrotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Aminoglycoside risk of ototoxicity)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Succimer",
        "Drug Class": "Heavy Metal Chelator",
        "Indications": "Lead poisoning",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Rash",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause rash and elevated liver enzymes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sucralfate",
        "Drug Class": "GI Protectant",
        "Indications": "Peptic ulcer disease",
        "Dosage Form": "Tablet",
        "Strength": "1 g",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Can decrease the absorption of many other drugs administer other drugs 2 hours before or after Can cause constipation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sufentanil",
        "Drug Class": "Opioid Agonist",
        "Indications": "Anesthesia",
        "Dosage Form": "Solution",
        "Strength": "30 mcg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "analgesia",
        "Contraindications": "Respiratory depression",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk Life-threatening respiratory depression may occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Opioid risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sulfacetamide",
        "Drug Class": "Sulfonamide Antibiotic",
        "Indications": "Bacterial eye infections",
        "Dosage Form": "Solution",
        "Strength": "10%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Stinging",
        "Contraindications": "burning",
        "Interaction warnings & Precautions": "No significant drug interactions For ophthalmic use only can cause local irritation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sulfadiazine",
        "Drug Class": "Sulfonamide Antibiotic",
        "Indications": "Toxoplasmosis",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "other infections",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "May potentiate the effects of warfarin and sulfonylureas Can cause crystalluria and Stevens-Johnson syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Kernicterus risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sulfamethoxazole",
        "Drug Class": "Sulfonamide Antibiotic",
        "Indications": "Bacterial infections (often combined with trimethoprim)",
        "Dosage Form": "Tablet",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "May potentiate the effects of warfarin and sulfonylureas Can cause Stevens-Johnson syndrome and blood dyscrasias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Kernicterus risk; usually with trimethoprim)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sulfasalazine",
        "Drug Class": "5-ASA Derivative",
        "Indications": "Ulcerative colitis",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "May reduce absorption of digoxin and folic acid Can cause oligospermia and orange-yellow discoloration of urine and skin.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Kernicterus risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sulfinpyrazone",
        "Drug Class": "Uricosuric",
        "Indications": "Gout",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GI upset",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Salicylates antagonize the uricosuric effect Can cause GI upset and blood dyscrasias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Kernicterus risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sulindac",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "gout",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sumatriptan",
        "Drug Class": "5-HT1 Agonist",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Chest pain",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other 5-HT1 agonists and MAOIs can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Sunitinib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Renal cell carcinoma",
        "Dosage Form": "Capsule",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "GIST",
        "Contraindications": "Fatigue",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hepatotoxicity and left ventricular dysfunction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tacrolimus",
        "Drug Class": "Calcineurin Inhibitor",
        "Indications": "Organ transplant rejection",
        "Dosage Form": "Capsule",
        "Strength": "1 mg",
        "Route of Administration": "Oral",
        "Side Effects": "immunosuppression",
        "Contraindications": "Nephrotoxicity",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause nephrotoxicity and neurotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tadalafil",
        "Drug Class": "PDE5 Inhibitor",
        "Indications": "Erectile dysfunction",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "BPH",
        "Contraindications": "PAH",
        "Interaction warnings & Precautions": "Nitrates can cause severe hypotension Can cause priapism and back pain.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tamoxifen",
        "Drug Class": "SERM",
        "Indications": "Breast cancer",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hot flashes",
        "Contraindications": "vaginal discharge",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors may decrease levels of active metabolite Increases risk of thromboembolism and endometrial cancer.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tamsulosin",
        "Drug Class": "Alpha-1 Blocker",
        "Indications": "BPH",
        "Dosage Form": "Capsule",
        "Strength": "0.4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Retrograde ejaculation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Can cause retrograde ejaculation and orthostatic hypotension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; not indicated for use in women",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tapentadol",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk MAOIs can cause serotonin syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tazarotene",
        "Drug Class": "Retinoid",
        "Indications": "Plaque psoriasis",
        "Dosage Form": "Gel",
        "Strength": "0.10%",
        "Route of Administration": "Topical",
        "Side Effects": "acne",
        "Contraindications": "Skin irritation",
        "Interaction warnings & Precautions": "No significant drug interactions Highly teratogenic females must use effective contraception.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tedizolid",
        "Drug Class": "Oxazolidinone Antibiotic",
        "Indications": "Bacterial skin infections",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "headache",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause myelosuppression and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data; likely C",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Telavancin",
        "Drug Class": "Lipoglycopeptide Antibiotic",
        "Indications": "Complicated skin infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "750 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Taste disturbance",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "QT-prolonging drugs may have additive effects Can cause nephrotoxicity and fetal toxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Telbivudine",
        "Drug Class": "Nucleoside Reverse Transcriptase Inhibitor",
        "Indications": "Hepatitis B",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Creatine kinase elevation",
        "Contraindications": "fatigue",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause myopathy and peripheral neuropathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Telithromycin",
        "Drug Class": "Ketolide Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Tablet",
        "Strength": "800 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other QT-prolonging drugs may have additive effects Contraindicated in myasthenia gravis due to risk of life-threatening respiratory failure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Telmisartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "80 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperkalemia",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Temazepam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Insomnia",
        "Dosage Form": "Capsule",
        "Strength": "15 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Temozolomide",
        "Drug Class": "Alkylating Agent",
        "Indications": "Brain tumors",
        "Dosage Form": "Capsule",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Valproic acid may decrease clearance Can cause severe myelosuppression and pneumocystis pneumonia prophylaxis is required.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Temsirolimus",
        "Drug Class": "mTOR Inhibitor",
        "Indications": "Renal cell carcinoma",
        "Dosage Form": "Solution",
        "Strength": "25 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Rash",
        "Contraindications": "asthenia",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause hyperglycemia and interstitial lung disease.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tenecteplase",
        "Drug Class": "Thrombolytic",
        "Indications": "Acute myocardial infarction",
        "Dosage Form": "Powder for Injection",
        "Strength": "50 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Bleeding",
        "Contraindications": "arrhythmia",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Can cause serious and fatal bleeding especially intracranial hemorrhage.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tenofovir",
        "Drug Class": "NRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hepatitis B",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Terazosin",
        "Drug Class": "Alpha-1 Blocker",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "BPH",
        "Contraindications": "Dizziness",
        "Interaction warnings & Precautions": "Other antihypertensive drugs can have additive effects Can cause marked first-dose hypotension and syncope.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Terbinafine",
        "Drug Class": "Antifungal",
        "Indications": "Fungal nail infections",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "other fungal infections",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors may increase levels Can cause taste disturbance and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Terbutaline",
        "Drug Class": "Beta-2 Agonist",
        "Indications": "Asthma",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bronchospasm",
        "Contraindications": "tocolysis",
        "Interaction warnings & Precautions": "Beta-blockers may antagonize the effects Can cause paradoxical bronchospasm and cardiovascular effects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Terconazole",
        "Drug Class": "Antifungal",
        "Indications": "Vaginal yeast infections",
        "Dosage Form": "Cream",
        "Strength": "0.80%",
        "Route of Administration": "Vaginal",
        "Side Effects": "Vaginal burning",
        "Contraindications": "itching",
        "Interaction warnings & Precautions": "No significant drug interactions For vaginal use only can cause vulvovaginal burning.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Teriparatide",
        "Drug Class": "Parathyroid Hormone Analog",
        "Indications": "Osteoporosis",
        "Dosage Form": "Solution",
        "Strength": "20 mcg/80 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Dizziness",
        "Contraindications": "leg cramps",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause orthostatic hypotension and increased risk of osteosarcoma.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Testosterone",
        "Drug Class": "Androgen",
        "Indications": "Hypogonadism",
        "Dosage Form": "Gel",
        "Strength": "5 mg/24 hr",
        "Route of Administration": "Topical",
        "Side Effects": "Acne",
        "Contraindications": "edema",
        "Interaction warnings & Precautions": "Corticosteroids may increase edema risk and anticoagulants may have increased effects Can cause polycythemia and increased risk of cardiovascular events.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tetrabenazine",
        "Drug Class": "Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor",
        "Indications": "Huntington's disease chorea",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "parkinsonism",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors may increase levels Can cause depression and suicidal ideation and is contraindicated in untreated depression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tetracycline",
        "Drug Class": "Tetracycline Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Capsule",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "acne",
        "Contraindications": "Photosensitivity",
        "Interaction warnings & Precautions": "Antacids and calcium supplements decrease absorption Can cause photosensitivity and tooth discoloration in children.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Tooth discoloration risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Thalidomide",
        "Drug Class": "Immunomodulatory Agent",
        "Indications": "Multiple myeloma",
        "Dosage Form": "Capsule",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "leprosy",
        "Contraindications": "Peripheral neuropathy",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Is a known human teratogen and requires strict pregnancy prevention program.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (STEPS program)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Theophylline",
        "Drug Class": "Xanthine Derivative",
        "Indications": "Asthma",
        "Dosage Form": "Tablet (ER)",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "COPD",
        "Contraindications": "bronchospasm",
        "Interaction warnings & Precautions": "Many drugs can increase (eg ciprofloxacin) or decrease (eg phenytoin) levels due to CYP1A2 metabolism Has a narrow therapeutic index and can cause seizures and arrhythmias in overdose.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Thioguanine",
        "Drug Class": "Antimetabolite",
        "Indications": "Leukemia",
        "Dosage Form": "Tablet",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and hepatotoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Thioridazine",
        "Drug Class": "Typical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Extrapyramidal symptoms",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "Strong CYP2D6 inhibitors are contraindicated due to risk of QT prolongation Can cause QT prolongation and retinopathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Thiotepa",
        "Drug Class": "Alkylating Agent",
        "Indications": "Various cancers",
        "Dosage Form": "Powder for Injection",
        "Strength": "15 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Myelosuppression",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tiagabine",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "12 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can cause seizures in patients without epilepsy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ticagrelor",
        "Drug Class": "P2Y12 Inhibitor",
        "Indications": "Acute coronary syndrome",
        "Dosage Form": "Tablet",
        "Strength": "90 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bleeding",
        "Contraindications": "dyspnea",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause dyspnea and serious bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ticarcillin-Clavulanate",
        "Drug Class": "Penicillin Antibiotic + Beta-Lactamase Inhibitor",
        "Indications": "Bacterial infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "3.1 g",
        "Route of Administration": "Intravenous",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Probenecid may decrease excretion May cause hypokalemia and bleeding diathesis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ticlopidine",
        "Drug Class": "Antiplatelet",
        "Indications": "Stroke prevention (alternative)",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "neutropenia",
        "Interaction warnings & Precautions": "Proton pump inhibitors may reduce its antiplatelet effect Can cause severe neutropenia and thrombotic thrombocytopenic purpura (TTP).",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tigecycline",
        "Drug Class": "Glycylcycline Antibiotic",
        "Indications": "Complicated infections",
        "Dosage Form": "Powder for Injection",
        "Strength": "50 mg",
        "Route of Administration": "Intravenous",
        "Side Effects": "Nausea",
        "Contraindications": "vomiting",
        "Interaction warnings & Precautions": "Warfarin metabolism may be affected increasing INR Can increase all-cause mortality and is reserved for use when alternatives are not suitable.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Timolol",
        "Drug Class": "Beta-Blocker",
        "Indications": "Glaucoma",
        "Dosage Form": "Solution",
        "Strength": "0.50%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "hypertension",
        "Contraindications": "angina",
        "Interaction warnings & Precautions": "Other drugs that lower heart rate or blood pressure can have additive effects Can cause bronchospasm in patients with asthma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Beta-blocker risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tinidazole",
        "Drug Class": "Nitroimidazole Antibiotic",
        "Indications": "Amebiasis",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "giardiasis",
        "Contraindications": "trichomoniasis",
        "Interaction warnings & Precautions": "Disulfiram-like reaction can occur with alcohol Can cause peripheral neuropathy and seizures with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tioconazole",
        "Drug Class": "Antifungal",
        "Indications": "Vaginal yeast infections",
        "Dosage Form": "Ointment",
        "Strength": "6.50%",
        "Route of Administration": "Vaginal",
        "Side Effects": "Vaginal burning",
        "Contraindications": "itching",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Tiotropium",
        "Drug Class": "Anticholinergic",
        "Indications": "COPD",
        "Dosage Form": "Capsule for Inhalation",
        "Strength": "18 mcg",
        "Route of Administration": "Inhalation",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tipranavir",
        "Drug Class": "Protease Inhibitor",
        "Indications": "HIV infection",
        "Dosage Form": "Capsule",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers are contraindicated as they significantly decrease levels Can cause hepatotoxicity and intracranial hemorrhage.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tirofiban",
        "Drug Class": "Glycoprotein IIb/IIIa Inhibitor",
        "Indications": "Acute coronary syndrome",
        "Dosage Form": "Solution",
        "Strength": "50 mcg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "Bleeding",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Can cause severe bleeding and thrombocytopenia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tizanidine",
        "Drug Class": "Alpha-2 Agonist",
        "Indications": "Muscle spasticity",
        "Dosage Form": "Tablet",
        "Strength": "4 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "Strong CYP1A2 inhibitors (eg fluvoxamine) can significantly increase levels Can cause hypotension and sedation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tobramycin",
        "Drug Class": "Aminoglycoside Antibiotic",
        "Indications": "Bacterial infections",
        "Dosage Form": "Solution",
        "Strength": "0.30%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "Nephrotoxicity",
        "Contraindications": "ototoxicity",
        "Interaction warnings & Precautions": "Other nephrotoxic or ototoxic drugs increase risk of toxicity Monitor peak and trough levels to minimize risk of nephrotoxicity and ototoxicity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Aminoglycoside risk of ototoxicity)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tocilizumab",
        "Drug Class": "IL-6 Receptor Antagonist",
        "Indications": "Rheumatoid arthritis",
        "Dosage Form": "Solution",
        "Strength": "162 mg/0.9 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Upper respiratory infection",
        "Contraindications": "increased cholesterol",
        "Interaction warnings & Precautions": "May increase metabolism of CYP450 substrates due to reversal of inflammation-induced suppression Can cause serious infections and gastrointestinal perforations.",
        "Storage Conditions": "Refrigerate",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tofacitinib",
        "Drug Class": "JAK Inhibitor",
        "Indications": "Rheumatoid arthritis",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "psoriatic arthritis",
        "Contraindications": "Upper respiratory infection",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tolazamide",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Sulfonylurea risk of hypoglycemia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tolbutamide",
        "Drug Class": "Sulfonylurea",
        "Indications": "Type 2 diabetes",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hypoglycemia",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Drugs that increase hypoglycemia risk (eg beta-blockers) Can cause severe and prolonged hypoglycemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (Sulfonylurea risk of hypoglycemia)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tolcapone",
        "Drug Class": "COMT Inhibitor",
        "Indications": "Parkinson's disease",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "urine discoloration",
        "Interaction warnings & Precautions": "Nonselective MAOIs are contraindicated Can cause hepatotoxicity requiring frequent liver monitoring.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tolmetin",
        "Drug Class": "NSAID",
        "Indications": "Osteoarthritis",
        "Dosage Form": "Capsule",
        "Strength": "400 mg",
        "Route of Administration": "Oral",
        "Side Effects": "rheumatoid arthritis",
        "Contraindications": "GI upset",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (NSAID risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tolnaftate",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections",
        "Dosage Form": "Solution",
        "Strength": "1%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin irritation",
        "Contraindications": "pruritus",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Tolterodine",
        "Drug Class": "Anticholinergic",
        "Indications": "Overactive bladder",
        "Dosage Form": "Capsule",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause blurred vision and urinary retention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Topiramate",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "migraine prevention",
        "Contraindications": "Weight loss",
        "Interaction warnings & Precautions": "Can decrease efficacy of oral contraceptives and other drugs by inducing CYP450 enzymes Can cause metabolic acidosis and angle-closure glaucoma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information (Cleft lip/palate risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Torsemide",
        "Drug Class": "Loop Diuretic",
        "Indications": "Edema (heart failure",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "hepatic",
        "Contraindications": "renal)",
        "Interaction warnings & Precautions": "Other ototoxic drugs may increase risk of hearing loss NSAIDs may reduce the diuretic effect Profound diuresis and electrolyte depletion can occur.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tramadol",
        "Drug Class": "Opioid Agonist",
        "Indications": "Pain",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Constipation",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "CNS depressants including alcohol and benzodiazepines increase sedation risk MAOIs and other serotonergic drugs can cause serotonin syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Trandolapril",
        "Drug Class": "ACE Inhibitor",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "2 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "Cough",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ACE Inhibitor risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tranexamic Acid",
        "Drug Class": "Antifibrinolytic",
        "Indications": "Heavy menstrual bleeding",
        "Dosage Form": "Tablet",
        "Strength": "650 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bleeding prevention",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause thrombosis and visual disturbances.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Trazodone",
        "Drug Class": "Serotonin Antagonist and Reuptake Inhibitor (SARI)",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "insomnia",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause priapism a medical emergency.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Treprostinil",
        "Drug Class": "Prostacyclin Analog",
        "Indications": "Pulmonary arterial hypertension (PAH)",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Headache",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Other vasodilators or antihypertensive drugs can have additive effects Can cause infusion site pain and reaction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tretinoin",
        "Drug Class": "Retinoid",
        "Indications": "Acne vulgaris",
        "Dosage Form": "Cream",
        "Strength": "0.05%",
        "Route of Administration": "Topical",
        "Side Effects": "Skin dryness",
        "Contraindications": "erythema",
        "Interaction warnings & Precautions": "No significant drug interactions Highly teratogenic and can cause severe skin irritation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Triamcinolone",
        "Drug Class": "Corticosteroid",
        "Indications": "Inflammatory conditions",
        "Dosage Form": "Ointment",
        "Strength": "0.10%",
        "Route of Administration": "Topical",
        "Side Effects": "Hyperglycemia",
        "Contraindications": "fluid retention",
        "Interaction warnings & Precautions": "CYP3A4 inducers (eg phenytoin) may decrease efficacy and inhibitors may increase effects Can cause hyperglycemia and adrenal suppression with prolonged use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Triamterene",
        "Drug Class": "Potassium-Sparing Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "50 mg",
        "Route of Administration": "Oral",
        "Side Effects": "edema",
        "Contraindications": "Hyperkalemia",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may increase risk of hyperkalemia Can cause hyperkalemia and kidney stones.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Triamterene-Hydrochlorothiazide",
        "Drug Class": "Potassium-Sparing Diuretic + Thiazide Diuretic",
        "Indications": "Hypertension",
        "Dosage Form": "Capsule",
        "Strength": "37.5/25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Hyperkalemia",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "ACE inhibitors and ARBs may increase risk of hyperkalemia and other drugs that lower potassium may have additive effects Can cause electrolyte imbalances including hyperkalemia and hypokalemia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information (ACE Inhibitor/Thiazide risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Triazolam",
        "Drug Class": "Benzodiazepine",
        "Indications": "Insomnia",
        "Dosage Form": "Tablet",
        "Strength": "0.25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors are contraindicated due to risk of profound sedation Can cause anterograde amnesia and severe sedation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Trifluoperazine",
        "Drug Class": "Typical Antipsychotic",
        "Indications": "Psychotic disorders",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Extrapyramidal symptoms",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects Can cause extrapyramidal symptoms and neuroleptic malignant syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Trimethoprim",
        "Drug Class": "Antibiotic",
        "Indications": "UTIs (often combined with sulfamethoxazole)",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "May increase levels of phenytoin and digoxin Can cause hyperkalemia and blood dyscrasias.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Trimipramine",
        "Drug Class": "Tricyclic Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Capsule",
        "Strength": "25 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "sedation",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome and hyperpyrexia Strong anticholinergic effects may occur with other drugs Increased risk of suicide in children and young adults.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Triprolidine",
        "Drug Class": "Antihistamine",
        "Indications": "Allergic rhinitis",
        "Dosage Form": "Syrup",
        "Strength": "2.5 mg/5 mL",
        "Route of Administration": "Oral",
        "Side Effects": "Sedation",
        "Contraindications": "dry mouth",
        "Interaction warnings & Precautions": "CNS depressants may enhance sedative effects May cause marked drowsiness and impair mental and physical abilities.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Triptorelin",
        "Drug Class": "GnRH Agonist",
        "Indications": "Prostate cancer",
        "Dosage Form": "Powder for Injection",
        "Strength": "3.75 mg",
        "Route of Administration": "Intramuscular",
        "Side Effects": "endometriosis",
        "Contraindications": "Hot flashes",
        "Interaction warnings & Precautions": "No significant drug interactions Causes an initial increase in testosterone levels which may worsen symptoms in prostate cancer patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Tropicamide",
        "Drug Class": "Anticholinergic",
        "Indications": "Ocular cycloplegia",
        "Dosage Form": "Solution",
        "Strength": "1%",
        "Route of Administration": "Ophthalmic",
        "Side Effects": "mydriasis",
        "Contraindications": "Blurred vision",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Contraindicated in patients with angle-closure glaucoma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Trospium",
        "Drug Class": "Anticholinergic",
        "Indications": "Overactive bladder",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause blurred vision and urinary retention.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Umeclidinium",
        "Drug Class": "Anticholinergic",
        "Indications": "COPD",
        "Dosage Form": "Inhaler",
        "Strength": "62.5 mcg/actuation",
        "Route of Administration": "Inhalation",
        "Side Effects": "Dry mouth",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "Other anticholinergic drugs can have additive effects Can cause paradoxical bronchospasm and narrow-angle glaucoma.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Undecylenic Acid",
        "Drug Class": "Antifungal",
        "Indications": "Fungal skin infections (e.g.",
        "Dosage Form": "Ointment",
        "Strength": "25%",
        "Route of Administration": "Topical",
        "Side Effects": "athlete's foot)",
        "Contraindications": "Skin irritation",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only not for ophthalmic use.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "No data",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Urea",
        "Drug Class": "Keratolytic",
        "Indications": "Dry skin",
        "Dosage Form": "Cream",
        "Strength": "40%",
        "Route of Administration": "Topical",
        "Side Effects": "xerosis",
        "Contraindications": "hyperkeratotic conditions",
        "Interaction warnings & Precautions": "No significant drug interactions For topical use only can cause mild irritation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "No prescription required"
    },
    {
        "Generic Name": "Urokinase",
        "Drug Class": "Thrombolytic",
        "Indications": "Pulmonary embolism",
        "Dosage Form": "000 unit",
        "Strength": "250",
        "Route of Administration": "Powder for Injection",
        "Side Effects": "Acute myocardial infarction",
        "Contraindications": "Bleeding",
        "Interaction warnings & Precautions": "Other drugs that affect hemostasis increase bleeding risk Can cause serious and fatal bleeding especially intracranial hemorrhage.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Intravenous"
    },
    {
        "Generic Name": "Ursodiol",
        "Drug Class": "Gallstone Dissolution Agent",
        "Indications": "Gallstones",
        "Dosage Form": "Capsule",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "primary biliary cholangitis",
        "Contraindications": "Diarrhea",
        "Interaction warnings & Precautions": "Aluminum-based antacids and cholestyramine may reduce absorption Generally well-tolerated with diarrhea being the most common side effect.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Valacyclovir",
        "Drug Class": "Antiviral",
        "Indications": "Herpes simplex virus (HSV) infections",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Varicella zoster virus (VZV) infections",
        "Contraindications": "Headache",
        "Interaction warnings & Precautions": "Probenecid may decrease acyclovir clearance increasing its levels Maintain adequate hydration to prevent nephrotoxicity especially in elderly or dehydrated patients.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Valganciclovir",
        "Drug Class": "Antiviral",
        "Indications": "Cytomegalovirus (CMV) retinitis",
        "Dosage Form": "Tablet",
        "Strength": "450 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Myelosuppression",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "Probenecid may decrease ganciclovir excretion Can cause severe myelosuppression and mutagenesis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Valproic Acid",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Capsule",
        "Strength": "250 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "migraine prevention",
        "Interaction warnings & Precautions": "CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Neural tube defect risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Valsartan",
        "Drug Class": "ARB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet",
        "Strength": "80 mg",
        "Route of Administration": "Oral",
        "Side Effects": "heart failure",
        "Contraindications": "post-MI",
        "Interaction warnings & Precautions": "NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information (ARB risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vancomycin",
        "Drug Class": "Glycopeptide Antibiotic",
        "Indications": "Serious bacterial infections (e.g.",
        "Dosage Form": "Capsule",
        "Strength": "125 mg",
        "Route of Administration": "Oral",
        "Side Effects": "MRSA)",
        "Contraindications": "Red man syndrome",
        "Interaction warnings & Precautions": "Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vandetanib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Thyroid cancer",
        "Dosage Form": "Tablet",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause QT prolongation torsades de pointes and sudden death.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vardenafil",
        "Drug Class": "PDE5 Inhibitor",
        "Indications": "Erectile dysfunction",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "flushing",
        "Interaction warnings & Precautions": "Nitrates can cause severe hypotension Can cause priapism and sudden hearing loss.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Varenicline",
        "Drug Class": "Nicotinic Acetylcholine Receptor Partial Agonist",
        "Indications": "Smoking cessation",
        "Dosage Form": "Tablet",
        "Strength": "0.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "abnormal dreams",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause serious neuropsychiatric events including depression and suicidal thoughts.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Varicella Vaccine",
        "Drug Class": "Vaccine",
        "Indications": "Prevention of varicella (chickenpox)",
        "Dosage Form": "Powder for Injection",
        "Strength": "1350 PFU/0.5 mL",
        "Route of Administration": "Subcutaneous",
        "Side Effects": "Injection site reactions",
        "Contraindications": "fever",
        "Interaction warnings & Precautions": "Immunosuppressive drugs may diminish the immune response Contraindicated in immunosuppression and pregnancy.",
        "Storage Conditions": "Frozen",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "Contraindicated; live vaccine",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vasopressin",
        "Drug Class": "Posterior Pituitary Hormone",
        "Indications": "Diabetes insipidus",
        "Dosage Form": "Solution",
        "Strength": "20 units/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "vasodilatory shock",
        "Contraindications": "Abdominal cramps",
        "Interaction warnings & Precautions": "Other drugs that can cause water intoxication may have additive effects Can cause hyponatremia and tissue necrosis with extravasation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vemurafenib",
        "Drug Class": "Kinase Inhibitor",
        "Indications": "Melanoma (BRAF V600E mutation)",
        "Dosage Form": "Tablet",
        "Strength": "240 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Arthralgia",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease efficacy Can promote the growth of certain skin cancers and cause QT prolongation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Venlafaxine",
        "Drug Class": "SNRI",
        "Indications": "Depression",
        "Dosage Form": "Capsule (ER)",
        "Strength": "75 mg",
        "Route of Administration": "Oral",
        "Side Effects": "anxiety disorders",
        "Contraindications": "Nausea",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome Can increase blood pressure and cause withdrawal symptoms upon discontinuation.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Verapamil",
        "Drug Class": "Non-Dihydropyridine CCB",
        "Indications": "Hypertension",
        "Dosage Form": "Tablet (SR)",
        "Strength": "120 mg",
        "Route of Administration": "Oral",
        "Side Effects": "angina",
        "Contraindications": "atrial arrhythmias",
        "Interaction warnings & Precautions": "CYP3A4 inhibitors can increase levels and inducers can decrease levels Can cause bradycardia and heart failure.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vigabatrin",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Tablet",
        "Strength": "500 mg",
        "Route of Administration": "Oral",
        "Side Effects": "infantile spasms",
        "Contraindications": "Sedation",
        "Interaction warnings & Precautions": "Other drugs that cause visual field defects may have additive effects Can cause permanent concentric visual field constriction.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vilazodone",
        "Drug Class": "Serotonin Partial Agonist and Reuptake Inhibitor (SPARI)",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Diarrhea",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome Can cause diarrhea and insomnia.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vinblastine",
        "Drug Class": "Vinca Alkaloid",
        "Indications": "Hodgkin's lymphoma",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "other cancers",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause severe myelosuppression and extravasation injury.",
        "Storage Conditions": "Refrigerate Protect from light",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vincristine",
        "Drug Class": "Vinca Alkaloid",
        "Indications": "Leukemias",
        "Dosage Form": "Solution",
        "Strength": "1 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "lymphomas",
        "Contraindications": "other cancers",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause severe peripheral neuropathy and extravasation injury.",
        "Storage Conditions": "Refrigerate Protect from light",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vinorelbine",
        "Drug Class": "Vinca Alkaloid",
        "Indications": "Non-small cell lung cancer",
        "Dosage Form": "Solution",
        "Strength": "10 mg/mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "breast cancer",
        "Contraindications": "Myelosuppression",
        "Interaction warnings & Precautions": "Strong CYP3A4 inhibitors may increase levels Can cause severe myelosuppression and extravasation injury.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Voriconazole",
        "Drug Class": "Azole Antifungal",
        "Indications": "Invasive fungal infections",
        "Dosage Form": "Tablet",
        "Strength": "200 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Visual disturbances",
        "Contraindications": "rash",
        "Interaction warnings & Precautions": "Inhibits CYP3A4 increasing levels of many drugs (eg statins) Can cause visual disturbances hepatotoxicity and photosensitivity.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Vortioxetine",
        "Drug Class": "Multimodal Antidepressant",
        "Indications": "Depression",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Nausea",
        "Contraindications": "constipation",
        "Interaction warnings & Precautions": "MAOIs can cause serotonin syndrome Can cause nausea and increased risk of bleeding.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Warfarin",
        "Drug Class": "Anticoagulant (Vitamin K Antagonist)",
        "Indications": "Thromboembolism prevention/treatment",
        "Dosage Form": "Tablet",
        "Strength": "5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Bleeding",
        "Contraindications": "skin necrosis",
        "Interaction warnings & Precautions": "A vast number of drugs can increase or decrease INR through various mechanisms Has a narrow therapeutic index and requires frequent INR monitoring to prevent bleeding or clotting.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Positive evidence of fetus risks but benefits may outweigh risks in some cases",
        "Reference": "FDA Prescribing Information (Warfarin embryopathy risk)",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zafirlukast",
        "Drug Class": "Leukotriene Receptor Antagonist",
        "Indications": "Asthma",
        "Dosage Form": "Tablet",
        "Strength": "20 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Warfarin metabolism is inhibited increasing INR Can cause hepatic failure and Churg-Strauss syndrome.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zaleplon",
        "Drug Class": "Non-Benzodiazepine Hypnotic",
        "Indications": "Insomnia",
        "Dosage Form": "Capsule",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "CNS depressants including alcohol increase sedation risk Can cause complex sleep behaviors like sleep-driving.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zanamivir",
        "Drug Class": "Neuraminidase Inhibitor",
        "Indications": "Influenza",
        "Dosage Form": "Powder for Inhalation",
        "Strength": "5 mg/Blister",
        "Route of Administration": "Inhalation",
        "Side Effects": "Nausea",
        "Contraindications": "diarrhea",
        "Interaction warnings & Precautions": "No significant drug interactions Can cause bronchospasm in patients with underlying airways disease.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zidovudine",
        "Drug Class": "NRTI",
        "Indications": "HIV infection",
        "Dosage Form": "Tablet",
        "Strength": "300 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Anemia",
        "Contraindications": "neutropenia",
        "Interaction warnings & Precautions": "Other bone marrow suppressants may have additive effects Can cause severe myelosuppression and myopathy.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Human studies have proved safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zileuton",
        "Drug Class": "5-Lipoxygenase Inhibitor",
        "Indications": "Asthma",
        "Dosage Form": "Tablet",
        "Strength": "600 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Headache",
        "Contraindications": "nausea",
        "Interaction warnings & Precautions": "Theophylline and warfarin levels may be increased Can cause hepatotoxicity and requires monitoring of liver enzymes.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Ziprasidone",
        "Drug Class": "Atypical Antipsychotic",
        "Indications": "Schizophrenia",
        "Dosage Form": "Capsule",
        "Strength": "40 mg",
        "Route of Administration": "Oral",
        "Side Effects": "bipolar disorder",
        "Contraindications": "Somnolence",
        "Interaction warnings & Precautions": "Other drugs that prolong the QT interval are contraindicated Can cause QT prolongation and rash.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zoledronic Acid",
        "Drug Class": "Bisphosphonate",
        "Indications": "Hypercalcemia of malignancy",
        "Dosage Form": "Solution",
        "Strength": "5 mg/100 mL",
        "Route of Administration": "Intravenous",
        "Side Effects": "bone metastases",
        "Contraindications": "Flu-like symptoms",
        "Interaction warnings & Precautions": "Nephrotoxic drugs may increase risk of renal impairment Can cause renal impairment and osteonecrosis of the jaw.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zolmitriptan",
        "Drug Class": "5-HT1 Agonist",
        "Indications": "Migraine attacks",
        "Dosage Form": "Tablet",
        "Strength": "2.5 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "Other 5-HT1 agonists and MAOIs can have additive effects Contraindicated in ischemic heart disease and uncontrolled hypertension.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Contraindicated (not allowed)",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zolpidem",
        "Drug Class": "Non-Benzodiazepine Hypnotic",
        "Indications": "Insomnia",
        "Dosage Form": "Tablet",
        "Strength": "10 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Dizziness",
        "Contraindications": "somnolence",
        "Interaction warnings & Precautions": "CNS depressants including alcohol increase sedation risk Can cause complex sleep behaviors like sleep-driving.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have demonstrated safety",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    },
    {
        "Generic Name": "Zonisamide",
        "Drug Class": "Anticonvulsant",
        "Indications": "Seizures",
        "Dosage Form": "Capsule",
        "Strength": "100 mg",
        "Route of Administration": "Oral",
        "Side Effects": "Somnolence",
        "Contraindications": "dizziness",
        "Interaction warnings & Precautions": "Strong CYP3A4 inducers may decrease levels Can cause oligohydrosis and hyperthermia in children and metabolic acidosis.",
        "Storage Conditions": "Room Temperature",
        "Pregnancy Category": "Animal studies have proved adverse effects but may be safe for humans",
        "Reference": "FDA Prescribing Information",
        "Availability": "Prescription"
    }
]